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Abstract
Chronic kidney disease (CKD) and Periodontal disease (PD) have been identified as
public health issues by both the Centers for Disease Control and Prevention and the
World Health Organization. The impact of PD on the health-related quality of life
(HRQoL) of the CKD patient is an area where there has been little research. Previous
research has not established a connection between PD and CKD although both diseases
share common inflammatory markers. The focus of this cross-sectional, quantitative
study was the possible impact of PD on the HRQoL of the CKD patient and the extent to
which a less than optimal mental health status (< 30 days of depressed mental state once
being diagnosed with CKD) plays a role. The health belief model and social construct
theory provided the theoretical framework for examining patient behavior and resultant
health outcomes. A random sampling (N = 96,787) was taken from the 2016 Behavioral
Risk Factor Surveillance Survey. Male and female participants in this study were 45-64
years, diagnosed with CKD and PD, had either no days of depressed mental state or less
than 30 days of depressed mental state. To analyze the data correlational, linear
regression, and ANOVA statistical analyses were performed using SPSS v25. The results
showed a statistically significant change of 6.8% in predicting the HRQoL of the CKD
patient when PD was present. This study has positive social change implications that
include increased collaboration between medicine and dentistry that may lead to
increased early diagnosis and treatment of PD, decreased incidence of inflammatory
systemic disease, increased positive rates of HRQoL, and improved overall health
outcomes.

The Impact of Periodontal Disease on the Health-Related Quality
of Life of the Chronic Kidney Disease Patient
by
Marlene M. Roberts

MS, University of Maryland University College, 2012
BS, University of Bridgeport, 1976

Doctoral Study Submitted in Partial Fulfillment
of the Requirements for the Degree of
Doctor of Public Health
Walden University
February 2021

Dedication
This is dedicated to my parents James, and Bertha Roberts, who first believed I
could accomplish whatever I set out to do and taught me the true meaning of dedicated
work, perseverance, and pursuing excellence. And to every patient dealing with chronic
systemic illnesses who desire to live a better life and have healthier outcomes. May the
information presented here act as another impetus towards a true collaborative approach
between the medical and dental health providers to achieve increased positive health
outcomes.

Acknowledgments
I would like to take this opportunity to recognize and acknowledge my Creator,
the One who is omnipotent and has sustained me to this point in my life. The Creator has
endowed me with gifts and talents of which I am at times unworthy of but am truly
grateful for, To my family, Marian, Kim, my church family, and the EB book club, all of
whom have continuously provided love, support, and encouragement on all levels
throughout this process. Without their unconditional love and support I could not have
reached this final stage. I could not have reached this milestone without the guidance,
support, and encouragement from my committee chair, Dr. Pelagia Melea, and
committee member, Dr. Jeanne Connors, who consistently demanded excellence and
attention to detail, and provided understanding when outside circumstances interrupted
this process. I thank you.

Table of Contents
List of Tables………………………………………………………………………iii
Section 1 – Foundation of the Study and Literature Review……………………

1

Background of the Study ……………………………………………………. 4
Problem Statement……………………………………………………………. 5
Purpose of the Study…………………………………………………………. 6
Research Questions and Hypotheses…………………………………………

7

Theoretical Foundations of the Study………………………………………..

8

Nature of the Study………………………………………………………….. 11
Literature Review …………………………………………………………… 13
Search Strategy
Literature Review Related to Key Variables…………………………………… 13
Introduction ……………………………………………………………… 13
Previous Research Addressing HRQoL of the CKD Patient ……………. 15
Linking PD to CKD ……………………………………………………… 17
Identifying Risk Factors of PD and CKD ……………………………… 20
Definitions …………………………………………………………………... 25
Assumptions ………………………………………………………………… 26
Scope and Delimitations ……………………………………………………. 27
Limitations of the Study ……………………………………………………. 27
Significance of the Study …………………………………………………… 28
i

Summary …………………………………………………………………………... 29
Section 2: Research Design and Data Collections …………………………………. 30
Introduction ……………………………………………………………………….30
Research Design and Rationale …………………………………………………...30
Data Collection and Analysis ………………………………………………...........33
Methodology ……………………………………………………………………….34
Population ………………………………………………………………………37
Sampling and Sampling Procedures ……………………………………………38
Data Analysis Plan ………………………………………………………………….38
Threats to Validity ………………………………………………………………….39
Summary ………………………………………………………………………………40
Section 3: Presentation of Results and Findings ………………………………………40
Data Collection from Secondary Data Set …………………………………………41
Results ………………………………………………………………………………44
Summary …………………………………………………………………….................54
Section 4: Application to Professional Practice and
Implications for Positive Social Change…………………………………………..55
Introduction ………………………………………………………………………….55
Interpretation of the Findings ………………………………………………………...56
Limitations of the Study …………………………………………………………….64
Recommendations ……………………………………………………………………64
ii

Implications for Positive Social Change ……………………………………………68
Conclusions …………………………………………………………………………….76
References ……………………………………………………………………………...80

iii

List of Tables
Table 1. t Test ……………………………………………………………….37
Table 2. Independent Samples T Test………………………………………..37
Table 3. Descriptive Statistics………………………………………………..44
Table 4. Demographics………………………………………………………45
Table 5. Correlational Analysis………………………………………………48
Table 6. Partial Correlational Analysis………………………………………50
Table 7. Regression Analysis………………………………………………..52
Table 8. Model Summary with ANOVA……………………………………54
Table 9. ANOVA Analysis………………………………………………….55
Table 10. Coefficients………………………………………………………56

iv

1
Section 1: Foundation of the Study and Literature Review
Chronic kidney disease (CKD) has become increasingly prevalent both in the
United States and globally (Maragkos et al., 2017). According to the Centers for Disease
Control and Prevention (CDC), approximately 15% of all U.S. adults (37 million) are
affected by CKD which has been identified as the ninth leading cause of death
(www.cdc.gov/CKD). The rise of CKD in the U. S. adult population was confirmed to be
20% higher in 2016 compared to the rates between 1988-1994 (www.cdc.gov/CKD). The
prevalence rate of CKD among adults in the U. S. has been calculated at 38% and is more
common among those aged >60 years followed at a rate of 13% for those aged 45-64
years (https://nccd.cdc.gov/CKD). Chronic low-grade inflammatory status is a hallmark
of CKD (Ismail et al., 2013). Sharma et al. (2017) identified cardiovascular disease as a
major cause of death among CKD patients. The presence of this chronic low-grade
inflammatory status increases the risk of CVD for the CKD patient. Statistics from the
2019 CDC website show periodontal disease (PD) affects 14% of the U. S. adult
population aged 45-64 years and 23% of those aged 65-74 years (www.cdc.gov/faststats).
PD is a chronic inflammatory process which can affect a patient’s quality of life, leading
to pain, disability, and the CKD patient’s self-efficacy (Baker et al., 2016). Six of every
ten U..S adults suffer from two or more chronic systemic diseases increasing the burden
of comorbidities, cost of treatment, and decreased positive health outcomes
(www.cdc.gov/chronicdisease/about/index.htm).
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The American Academy of Periodontology (AAP) defines PD as an infection of the
oral cavity that can result in tooth loss when left untreated. It is a chronic inflammatory
condition which can inflame and destroy gingival tissue, the periodontal ligaments, and
the alveolar bone of the periodontium. PD is characterized by bleeding gum tissues,
soreness, and pain when chewing, and malodor and is a distinct sign of poor oral health
(http://www.perio.org). PD is a common chronic inflammatory condition affecting
11.2% of the global population and contributes to the inflammatory burden of systemic
diseases such as CKD (Sharma et al., 2017). Untreated PD can progress to the more
severe form of periodontitis which is nonreversible. It is most often present in CKD
patients (Kim et al., 2017) contributing to the increased presence of the inflammatory
process resulting in worsened CKD status (Soroye & Ayanbadejo, 2016).
According to the 2019 CDC website, CKD is a chronic systemic inflammatory
disease affecting 15% of the adult U.S. population and is often undiagnosed in the early
stages. CKD patients are at an increased risk of heart disease, stroke, and early death
(www.cdc.gov/faststats). Chronic low-grade inflammation is a hallmark of CKD and is
one of many contributory factors in inflammation (Mihai et al., 2018). The persistent
low-grade inflammation seen in CKD patient is similar to the same type of low-grade
inflammation identified in PD (Grubbs et al., 2016). Anxiety and depression are quite
common in CKD patients more so than in the general population and is a major factor in
non-compliance with treatment, non-adherence to dietary guidelines, increased
hospitalizations, decreased quality of life and increased mortality rates (Yucens et al.,
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2019). HRQoL for the CKD patient is greatly affected by their mental health status
because it influences how much of the patient’s attention is focused on managing their
illness and improving their overall health outcomes (Wang et al., 2019) and should be
considered when assessing the HRQoL.
The association between these two chronic inflammatory diseases has been examined
in previous research studies as early as 2011 (Fearing Tornwall et al., 2012; Grubbs et al.,
2011; and Ismail et al., 2013). These studies examined the association between the
presence of PD in a majority of CKD patients in an effort to establish PD as a risk factor
for CKD. The study by Ismail et al. (2013) concluded that the hypotheses linking PD as a
factor in CKD via the inflammatory response is credible. The authors further stipulated
inflammation as a strong predictor of overall health outcomes, especially in end-stage
renal disease (ESRD) patients. Araujo et al. (2015) identified chronic PD as highly
prevalent in CKD patients aligned with malnutrition and inflammation. Early diagnosis
and treatment of PD may result in reduced systemic inflammation as demonstrated in a
study by Grubbs et al. (2016). A healthier diet with improved nutritional status may well
afford the CKD patient a better HRQoL status. This aspect was shown by Siou-Hung
Tsai et al. (2015) where poor nutrition, increased anxiety, and depressed mental status,
affected the patients’ health outcomes. The ability of the CKD patient to eat a healthy
diet consisting of anti-inflammatory nutrients and vitamins is a key factor in combatting
illness and supporting better health. Treatment of PD in its early stages can result in
improved oral health and increased HRQoL for the CKD patient (Haag et al., 2017).
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Background of the Study
There have been several studies and reviews of the research on PD and systemic
diseases (i.e., diabetes and cardiovascular disease, specifically atherosclerotic heart
disease) (Bansal et al., 2013; French et al., 2018; Han et al., 2013; Ismail et al., 2013;
Kim et al., 2017) but none have demonstrated the effect of PD on the HRQoL as related
to kidney disease. The established link between PD and CVD was a result of all the
aforementioned studies and has led to the practical application of collaborations between
the medical and dental professions in the care and treatment of the patient experiencing
atherosclerotic heart disease. Although studies as early as 2009 by Kshirsogar et al., and
Grubbs et al.(2011) gave credibility to the hypothesis of a correlation between PD and
CKD, current studies on this association are not focused on the HRQoL for the CKD
patient. The HRQoL of a patient is an important measure to help determine the health
outcomes of the patient with ESRD (Queeley & Campbell, 2018).
This quantitative cross-sectional study was undertaken to show the significance of
PD in assessing its impact on the HRQoL for the CKD patient. Measurement of the
HRQoL is a critical tool used by clinical providers to evaluate the efficacy of treatments
for the chronically ill (Queeley & Campbell, 2018). Increased collaborative efforts
between the medical and dental health disciplines could improve the care and treatment
of the patient suffering from chronic systemic diseases which could lead to decreased
cost of care and improved health outcomes. Effective treatment of PD may improve the
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status of CKD just as it mitigated the morbidity and mortality of atherosclerotic
cardiovascular disease (Bale et al.,2017).
Problem Statement
Increased collaboration between the medical and dental professions I needed; it
should include a precursory oral exam, performed by the doctor, as a part of the routine
physical examination (Myers-Wright & Lamster, 2016). The earlier a diagnosis is made
the earlier treatment can begin to establish a quicker path to better health and improved
HRQoL for the patient (Nazir, 2020). The moderate to severe form of PD has a higher
prevalence in the CKD patient population (Kim et al., 2017). The dental visit provides an
opportunity for the oral health care provider to identify early on in the process if there are
systemic or chronic inflammatory conditions present by performing a simple chairside
screening (Dolce et al., 2019). According to the CDC six of every ten Americans are
dealing with two or more chronic illnesses (www.cdc.gov/hronicdisease/about/index.htm)
which increases the impact of comorbidities on health outcomes. An approach that
examines the common risk factor of the inflammatory process which is present in both
PD and CKD, could result in decreased inflammation and slowed progression through the
stages of CKD (Grubbs et al., 2016).
Hang et al. (2017) concluded that there are risk factors shared by oral and systemic
chronic diseases which affect the health-related quality of life (HRQoL) of the patient.
Their work also showed edentulism and dental decay as having a negative effect on
HRQoL. Armed with this information one can make the argument that PD does have an
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effect on the HRQoL because tooth loss has been reported as a characteristic of PD in
studies by Maragos et al.(2017) and others (French et al., 2018; Grubbs et al., 2017).
Studies conducted earlier by Han et al.(2013) and Araujo et al.(2015) called for
additional research to provide evidence that would encourage increased medical and
dental collaborations. These collaborative efforts would provide earlier diagnoses and
treatment of PD to improve the HRQoL and health outcomes of the CKD patient. The
impact of chronic diseases such as PD on the HRQoL of the CKD patient has not been a
focus of research studies which leaves a gap in the literature. The results of this study
sought to provide additional information on the effect of PD on the CKD patient’s
HRQoL.
Purpose of the Study
The purpose of this quantitative, cross-sectional study was to determine if there is a
statistical significance in the presence of PD on the predicted outcome of the HRQoL of
the CKD patient. The results of this study may affect an increase in the collaborative
efforts between medical and dental providers for early diagnosis and treatment of PD.
Correlation and regression analyses with ANOVA test results of this study provide
evidence to support or nullify the hypothesis related to the impact of the independent
variable, PD, on the dependent variable, HRQol, adjusting for mental health status.
Dialysis treatment for the CKD patient can have negative effects on the HRQoL and lead
to less-than-optimal health outcomes (Wang et al., 2019). The importance of the HRQoL
cannot be overstated as it is considered an essential component of the CKD patient’s
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overall well-being (Queeley & Campbell, 2018). Previous research has shown how a
patient’s ability to manage their health care successfully has improved their overall health
outcomes (Havas, Douglas & Bonner, 2018). Examination of the hypothesized link
between periodontal treatment and decreasing the inflammatory process was studied
earlier by Han et al.(2013) and was supported in a later study Bale et al.,2017). The
evidence collected in both studies did not appear to have a marked increase in
collaborations between the medical and dental professions. Additional studies on a
relationship between PD therapy/treatment and improved health outcomes have not been
done.
Research Questions and Hypotheses
The purpose of this study was to determine if there was any statistical significance
to the presence of PD on the predictions of the HRQoL of the CKD patient. This study
was guided by the following research questions:
RQ1: Is there a statistical significance in the presence of PD on the predicted
HRQoL of the CKD patient?
H0: There is no statistical significance in the presence of PD on assessing the
HRQoL of the CKD patient.
H1: There is a statistical significance in the presence of PD on the predicted
HRQoL of the CKD patient when compared to those patients with no PD present.
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RQ2: Is there a statistical significance in the predicted HRQoL of the CKD
patient with a diagnosis of PD and less than 30 reported days of depression (mental
health) once being diagnosed with CKD (regardless of time of diagnosis)?
H02: There is no statistical significance in the predicted HRQoL of the CKD
patient diagnosed with PD and less than 30 reported days of depression (mental health)
once being diagnosed with CKD (regardless of time of diagnosis).
H12: There is a statistically significant difference in the predicted HRQoL of the
CKD patient when PD and less than 30 reported days of depression (mental health) once
being diagnosed with CKD (regardless of the time of diagnosis).
Theoretical Foundations for the Study
The social cognitive theory (SCT) and the health belief model (HBM) constitute the
theoretical foundation of this study. Both theories include constructs which are directed
toward motivating/affecting a change in a person’s behavior and/or lifestyle (Glanz,
Rimer & Viswanath, 2015). A major construct of the SCT is self-efficacy which
represents a person’s belief that they can accomplish and achieve a set of goals and tasks
which they agree to. Personal, environmental, and behavioral influences all intersect in a
dynamic manner to produce a behavior. Other constructs of the SCT include selfregulation and social support which can be designed to meet the specific needs and mores
of cultural and ethnic subpopulations (Joseph et al., 2017). The SCT has been used for
many years by clinicians and researchers to identify factors in health behavior, which in
turn are essential in designing interventions to bring about behavior change (Glanz et al.,
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2015). Ramsay et al.(2018) reported improved oral health status in patients who were
given oral hygiene advice tailored to meet their needs. This represents an example of
designing a framework for a specific subpopulation. There are three factors working in
the SCT model that determine the likelihood of a person changing their health behavior –
self-efficacy, the goals they set for themselves, and expected outcomes. The interaction
of these three factors results in learned and effective behavior change (Beeson, Whitney
& Peterson, 2017).
The HBM uses similar constructs and is widely accepted as a model in health
education programs (Glanz et al., 2015). The HBM examines a person’s relationship
between their health beliefs and their health behaviors. It looks at their perceived risk of
the disease, the severity of the disease (should they acquire it), the perceived benefits and
barriers to making a change in their behavior, and the decision to act. The major
suppositions of the HBM theory are as follows: a person will most likely make a change
in health behavior when they believe they are at risk for getting a condition (i.e.,
advanced progression of kidney disease), make changes in behavior when they perceive
the condition can have serious consequences (i.e., bad mouth odor, loss of teeth), take
action that could lead to decreased susceptibility or severity of the condition (i.e.,
decreased oral inflammation leading to lowered inflammatory process of kidney disease),
and recognize that the benefits of taking action outweigh the existing or perceived
barriers (i.e., cost of care, inconvenience) [Glanz et al., 2015]. HRQoL represents a
person’s own definition of how well they are living their life and their level of
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satisfaction with their life, their personal sense of well-being, their perception of their
independence, and the ability to have control over their life path (Kafkia, VahvilainenJulkunen & Sapountzi- Krepia, 2017). This definition of HRQoL is aligned with the core
concepts of the HBM theory and demonstrates how the theory is a foundation for this
study.
The oral health literacy of both the CKD patient and their medical provider is an
essential component of the response to periodontal treatment and improved health
outcomes. Knowledge of the risks and oral health complications of PD as it relates to
general health is most important when translating information to the CKD patient and
their medical providers. The CKD patient’s perceptions and beliefs about the relationship
between the inflammatory processes of both PD and CKD can definitively help increase
the CKD patient’s response to oral health care. The HBM is an example of a cognitive
approach. This approach explains the relationship between the person’s beliefs (perceived
threats, benefits) and the effects of what motivates a change in behavior at the decisionmaking level (Bakan, 2018).
Increased health literacy of the patient is important to understanding the correlation
between systemic inflammatory diseases. For the CKD patient, identification, and
confirmation of the association between the inflammation in CKD and the inflammatory
process of PD may result in a change in their oral health behavior. The CKD patient may
seek regular dental care. Increased self-management in the treatment of PD may also
serve to raise the CKD patient’s social capital by improved oral health and improved oral
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hygiene (Coll-Planas et al., 2018). Lee and Jung (2018) concluded that social capital does
affect health via the psychosocial mechanisms. These mechanisms include social support
from family and community, social influence, actively engaging with others, and having
personal contact. Social capital is considered a protective health factor impacting health
outcomes (Coll-Planas, 2018). Raising the oral health literacy of the medical provider
would also be helpful in increasing the needed collaboration between medicine and
dentistry professionals.
Nature of the Study
This epistemological study used a quantitative, cross-sectional approach to examine
the impact of PD and its possible effects on the HRQoL of the CKD patient. The purpose
of this study was to determine the statistical significance of the presence of PD in the
predicted outcome of the HRQoL of the CKD patient. This cumulative cross-sectional
approach focused on male and female adults aged 45-64 years old who were diagnosed
with kidney disease with no consideration of race/ethnicity.
The population for this study represented a large section of adults in the labor force that
is the second largest age group affected by CKD
(https://nccd.cdc.gov/CKD/AreYuAwarer.aspx?emailDate=September2020).
Determinants of race, education, and income levels were identified but were not
translated into independent or independent variables for consideration of their impact on
the outcome of the HRQoL.
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The study participants represented a 20% random sampling (N = 96,787) of the
2016 Behavioral Risk Factor Surveillance Survey (BRFSS) as conducted via telephone
across the U.S. by approved interviewers. The BRFSS comprised 275 variables and had a
total of 486, 987 respondents. The measurement tool to assess and identify PD as
presented by the American Academy of Periodontology (AAP) is multifactorial and is
considered complex by some dental professionals (G. Caton et al., 2018). The AAP’s
guidelines to assess PD does include but is not limited to the following: a clinical
examination of probing depths (consisting of measuring six points along each tooth’s
circumference), measuring tooth mobility, loss of attached gingival tissue, and loss of
alveolar bone around each tooth (http://www.perio.org). These values were not available
in the 2016 BRFSS database therefore, the presence of PD relied on the participants
response to the survey question of “number of missing teeth due to gum disease”.
The 2016 BRFSS study was chosen because the questions in the survey were related
to the key variables of the research study and provided the data needed to answer the
research questions and hypotheses. Results of the 2016 BRFSS study were compiled and
made available for public release in 2018, making it the most recent data for this
quantitative study. Correlation analysis was used to determine whether the presence of
PD is statistically significant in the predicted HRQoL as self-reported when compared to
the predicted HRQoL of the CKD patient with no diagnosis of PD. Regression analysis
was performed to examine the significance of the relationship between the CKD patients’
HRQoL status as self-reported and the presence of PD and mental health status (i.e., days
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of depression). Descriptive and inferential statistical analyses were used in this study for
identification and predictive purposes in answering the research questions and
hypotheses.
Literature Review
Search Strategy
To identify prospective, peer-reviewed articles (as well as books and grey literature),
the following electronic databases, ABI/Inform, CINAHL, and Medline were searched
for the years 2016-2020 using the following keywords: chronic kidney disease,
periodontal disease, health-related quality of life, and mental health status. Search terms
and phrases used to collect information and research articles were periodontal disease,
chronic kidney disease, chronic kidney disease, depression, health-related quality of life,
periodontal disease classification, inflammatory process + periodontal disease + chronic
kidney disease, periodontal disease + health-related quality of life, and quality of life +
chronic kidney disease patients. Additional information for this study was taken from
textbooks available through the Walden University classroom.
Literature Review Related to Key Variables
Introduction
The purpose of this study was to determine if there was statistical significance in the
presence of PD on the predicted outcome of the HRQoL of the CKD patient. Research on
the subject matter of a hypothesized link between PD and CKD has led to several
research studies (Bansal et al., 2013; Grubbs et al., 2017; Kiany et al., 2013) which have
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cited an association between the inflammation present in PD and the inflammatory
process which is seen in CKD and other systemic diseases. Studies by Okubo et al.
(2014) and Pagels et al. (2012) examine the relationship between HRQoL and the
progression of CKD leading to end-stage renal disease (ESRD) but do not address any
influence which PD has on the stages of disease progression in CKD. Okubo et al.
(2014) stated that HRQoL has an inverse relationship with the progression of stages in
CKD where the HRQoL decreases as the progression of the disease increases. The
current literature does not specifically address the effects of PD on the HRQoL for the
CKD patient but the shared risk factors of elevated pro-inflammatory cytokines and
triggered innate immune response systems which are present in both PD and CKD are
enough of an impetus to further investigate this hypothesized link. A study by Grubbs et
al.(2017) is currently underway to examine how nonsurgical treatment of PD may affect
the health outcome and progression of CKD. I believe this study to be an important step
towards understanding the impact of how the presence of PD and its manifestations in the
oral cavity can adversely affect the health outcomes of the patient diagnosed with
systemic illness such as CKD. Grubbs et al. (2017) states in their study that their purpose
in exploring this connection can possibly demonstrate how the CKD patient’s health
outcomes are affected by PD and how it relates to their self-esteem, social engagement,
and daily living. Results of this randomized controlled study are not currently published.
Another study by Haag et al. (2017) also demonstrates that there is a need to examine the
relationship between the integratory factors of oral and general health policies that are
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directly associated with the common risk factors that appear in both PD and CKD. Haag
et. (2017) states the weight of chronic conditions (such as PD), combined with underlying
and preexisting risk factors shared with other systemic diseases has increased and it
would be prudent to further investigate this relationship and its impact on the HRQoL for
the patient. The presence of PD can and generally does lead to tooth loss which has a
negative effect on overall health, issues of self-efficacy, decreased social capital and
well-being, and lessened quality of life (Hewlett et al., 2015).
Previous Research Addressing HRQoL of the CKD Patient
Limited existing research was available that studied or explored the link between the
presence of PD and its impact on the HRQoL for the CKD patient. The literature review
did reveal studies which were conducted to examine the effect of treating PD and the
resulting oral health outcomes for the CKD patient but did not directly address how the
HRQol was affected. The lack of existing research addressing the effect of PD on the
HRQoL for the CKD patient limited my exploration of this topic. However, this study
does afford some insight into and provides relevant evidence for supporting the need for
increased collaborative efforts between the medical and dental communities in early
diagnosis and treatment of PD in an effort to curtail systemic inflammation. Studies by
Soroye & Ayanbadejo (2016) postulated that PD is a risk factor for non-communicable
diseases (diabetes mellitus, CVD, pulmonary, and CKD) where the results of the study
demonstrated there were oral complications of renal disease, most notably bad mouth
odor, loose teeth, and inflamed salivary glands. These oral complications can be related
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to the construct of developing the social capital of the patient. Social capital is an
important aspect of the community and its members where social determinants and
environmental policies are major factors in determining the health and well-being of a
population (Glanz et al., 2015). Further examination of the relationship between social
capital can be identified by the definition of the term, “social epidemiology”. This term
has been defined as a branch of epidemiology that considers how a population’s
collective interactions and activities has an effect on their health (Ford et al., 2019). This
study was conducted to purposely explore the relationship between the presence of PD
and how the patient’s perception of their control or lack thereof, may alter their health
outcomes. Controlling the disease process of PD and its characteristics of bleeding gums,
bad mouth odor, loss of teeth, and decreased masticatory functions is a primary concern
in this study. Early diagnosis followed by intervention and dental therapy are key
components in increased patient compliance to prevention and regular dental care.
Lee and Jung (2018) presented a model of the impact of social capital on health
outcomes. This model explained that social conditions experienced by the patient results
in the patient’s social capital. The social-structural conditions (socioeconomic factors,
politics of health policies, social change) provides the opportunities for social networks to
exist. In turn, these networks influence the social support systems through personal
contact that is a pathway to health behaviors. The patient’s perception of their selfefficacy is tied to whether or not they decide to act and effect a change in their health
behaviors based on their perceived susceptibility if no action is taken (Glanz et al., 2015).
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Manavalan et al.(2017) socioeconomic factors were the dominant influencers of the
HRQoL rates of the CKD patient. Their study also found that the HRQoL of the CKD
patient was lacking and needed more exploration. Effective self-management for the
CKD patient as with other patients who have systemic inflammatory conditions, should
include proper diet and nutrition, adherence to medication regimen and cessation of
smoking to improve their health outcomes (Havas et al., 2018).
Linking PD to CKD
Most CKD patients have been diagnosed with PD (Kim et al., 2017) which indicates
the presence of an inflammatory process since PD is characterized by low-grade
inflammation and persistent infection caused by gram-negative bacteria. This gramnegative bacterium is present in dental plaque biofilm and is a substance which is formed
and deposited on teeth and gingival surfaces in the oral cavity (Soroye & Ayanbadejo,
2016). A mechanism for modulating systemic diseases via gingival inflammation was
proposed by Bansal et al. (2013) to help understand how gingival inflammation may
affect systemic diseases. The mechanism the authors presented proposed gram-negative
bacteria found in gingival inflammation would trigger a release of cytokines (also known
as inflammatory mediators) as an innate immune response via periodontal pathogens.
This response then is shown to result in an attack on target organs such as the liver and
kidneys. A diagram of their proposed mechanism of inflammation displays the release of
the cytokines interleukin-6 (IL-6), interleukin-1 (IL-1), and tumor necrotizing factor-α
(TNF-α) as a result of gingival inflammation (defining characteristic of PD). Another
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cytokine which is released is C-reactive protein (CRP) and the elevated levels of this
cytokine is related to PD as demonstrated in a later study led by Bansal (Bansal, Pandey
and Asthana, 2014). The work of Bansal et al.(2013) in their mechanism of inflammation
was supported by a subsequent study conducted by Araujo et al. (2015) concluding
ESRD patients diagnosed with PD have increased levels of periodontal pathogens
compared to those persons without ESRD.
The presence of elevated levels of CRP was concluded as a contributing factor in
CKD progression via the inflammatory response by Ismail et al. (2013) and was also
supported by Han et al. (2013) which was the first to establish a link between PD and
CKD inflammatory biomarkers in Korean adults. In this study of Korean adults
diagnosed with CKD, periodontitis was identified as an independent predictor of a
decreased estimated glomerular filtration rate (eGFR), which indicates how well the
kidneys are functioning. The study also found a correlation between PD and hematuria
which is also a critical marker of kidney damage. This is additional evidence which
suggests an association between PD and the presence of CKD. These studies were
followed by a study done by Nowak & Choncol (2018) which examined the
inflammatory markers present in CKD patients and their association with adverse clinical
outcomes. Nowak & Choncol (2018) identified CRP as an acute phase reactant leading to
a more impactful role in the inflammatory/disease process of CKD and cardiovascular
events.
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Following the same pathway in exploring a correlation between PD and CKD,
Sharma et al. (2017) presented information and concluded in their study that the
inflammatory biomarkers of CRP and IL-6 are reliable predictors of cardiovascular
events and all-cause mortality in patients diagnosed with CKD. This information proved
to be significant because CVD is a primary cause of mortality in CKD patients (Bale et
al., 2017) further justifying linking the two inflammatory diseases of PD and CKD. All
the preceding information definitively demonstrates common risk factors do exist
between PD and CKD. Grubbs et al. (2016) stated in their study that PD is both a
“common and modifiable” risk factor when examining CKD and the implications for
progression for the disease. The study went further to suggest that PD can be a potential
means of reducing risks for CKD progression because PD is treatable and preventable.
Once the PD is treated and an optimum state of oral health is maintained it is assumed
that the progression of CKD can be mitigated with the reduction of inflammatory
mediators being present. The same inflammatory mediators that were identified as being
present in both PD and CKD such as C-RP (Haag et al., 2017). This present study
exhibited similar results when a correlational analysis was performed to show that a
statistical significance exists between the presence of PD and the presence of CKD with
the additional variable of the patient’s response of their health not being good (related to
the HRQoL).
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Identifying Risk Factors of PD and CKD
Much of the research focused on PD and CKD as sharing common risk factors
acknowledge the presence of the cytokines CRP, IL-1, IL-6, and TNF-α. Use of
identifying common risk factors as a means of treatment and intervention when dealing
with chronic systemic diseases such as PD and CKD does necessitate the integration of
health policies and procedures surrounding both oral and general health (Haag et al.,
2017). It would be wise to consider which risk factors are present in both conditions since
the treatment of one disease may positively affect the progression of the other and vice
versa. Myers, Wright and Lamster (2016) concluded in their study coordinated care is
deemed a required component of treating persons who are dealing with multiple chronic
diseases. Their study revealed two of every three older Americans are experiencing more
than one chronic disease and this number represents 66% of the health costs in the US.
The expected decrease in the financial burden of providing care for persons experiencing
comorbid conditions which share common risk factors should be enough to have a closer
look at the relationship between the presence of PD and CKD and how it may impact the
HRQoL of the CKD patient. Emphasis needs to be placed on providing patients who have
systemic illnesses with routine dental exams and early treatment to avoid complications
of inflammation, to decrease pro-inflammatory mediators and C-Reactive proteins to
combat the effects of PD on the patient’s compromised systemic health.
PD and CKD are both chronic low-grade inflammatory processes and share diabetes
mellitus and CVD as common risk factors (Nazir, 2017). The results of the descriptive
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analysis presented here in this study also shows that 1.98% of the survey respondents
were diagnosed with coronary disease and diabetes mellitus (see Table 4). It was
discussed in an earlier section how atherosclerotic cardiovascular disease has been linked
to the presence of PD which further demonstrates the common risk factor of CVD. A
research study by Taraz et al. (2014) produced results showing chronic inflammation as a
contributor to morbidity and mortality in the CKD patient. Nowak and Chonchol (2018)
asserts there are strong observational data that places high inflammatory levels in CKD
patients, associating those levels with less than desirable clinical outcomes in a number of
health conditions.
These inflammatory levels are evident through the high-risk gram-negative pathogens
in the PD process where PD can gain access to systemic circulation and result in kidney
damage (Grubbs et al., 2016). The access to systemic circulation inducing kidney damage
is triggered by an innate immune response as discussed earlier. This immune response
occurs through toll-like receptors carried out by a group of transmembrane proteins (e.g.,
CRP, IL-1, IL-6, TNF-α) descending on the target organs, the kidneys, leading to renal
failure (Grubbs et al., 2016). The results of the study by Grubbs et al.(2016) undeniably
demonstrate the common risk factors of the cytokines being present in both PD and CKD.
Another common risk factor which can exacerbate the progress of PD and CKD is
anxiety and depression and are considered measurements of a person’s physical and
mental health status by identifying the number of days considered healthy or unhealthy
contributing to the calculation of the patient’s HRQoL (Allen et al., 2015). The HRQoL
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is an important measure when assessing the health outcomes of the CKD patient. It is a
multidimensional concept which is a combination of the patient’s perception of their
physical, mental, and social well-being (Gemmell et al., 2016). Self-reported health was
identified in a previous study by Medina-Solis et al. (2014) as measure worthy tool in
epidemiology because it has an association with the morbidity rates of the present and
future. Different causes of death can be determined by the use of health care services
available. Depression is common among CKD patients due to limited physical function,
dietary changes, decreased social support from family and friends and required dialysis
treatments (Siou-Hung Tsai et al., 2015). A relationship between depression and marked
elevation of the pro-inflammatory cytokines in CKD patients was reported by Siou-Hung
Tsai et al. (2015) and the authors displayed evidence of a correlation between depression
and malnutrition in this same CKD patient population, further supporting the importance
of including depression as a risk factor. Results of this study revealed a link between
mental health status (depression) and CKD progression. The study included the reported
number of days of mental health not being good as a predictor in assessing the probability
of its’ impact on the reported number of days of physical health not being good
(HRQoL).
Schick-Makaroff, Molzahn & Kalfoss (2018) reported a depression prevalence rate
of 21.4%- 39.3% among the CKD patient population in their study. The increased
depression rates definitively provide a negative effect on hospitalization, clinical
outcomes, and mortality. This present study found a variation of 6.2% in the HRQoL of
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the CKD patient being attributed to the presence of PD and mental health status less than
optimal. One may look at the percentage of 6.2% and find that the number is not
significant in terms of an amount but that percentage can be translated to the financial
impact in dollars and how the cost savings would be beneficial to the government’s
health care funding agencies. ESRD treatment in the U.S. accounts for 6.3% of
Medicare’s annual expenditures with the HRQoL of the CKD patient declining with the
progression of the disease (Nguyen et al., 2018). The financial impact of providing care
for 37 million U.S. adults experiencing CKD continues to rise exponentially with stages
1-4 of CKD accounting for a 20% increase in 2016 than in the previous year
(www.cdc.gov/chronicdisease/about/index.htm).
Social Determinants of Health in Assessing the HRQoL of the CKD Patient
The construct of the HRQoL of the CKD patient consists of different aspects of the
patient’s life which include the psychological, physical, and social components and what
tools the patient uses to cope with their disease (Kafkia et al., 2017). The psychological
and physical components have already been discussed earlier but it is important to
consider and include the social aspect of the HRQoL which is inclusive of the social
determinants of health (income, education, socioeconomic status, and social capital).
These factors were identified by Manavalan et al. (2017) in their study as key influencers
which impacted the HRQoL of CKD patients. The social cognitive theory (SCT) is one of
two theoretical foundations on which this study is grounded. The SCT is important when
explaining the relationship between the individual and their interaction with the physical
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and social components which influence health behaviors (Wong et al., 2018). In the SCT
the individual regulates their health behaviors via a sense of control or self-efficacy. The
cognitive and environmental influences which can affect the CKD patient’s behavior and
perception of their status (HRQoL) are their outcome expectations of their actions
regarding their health and the social support received in their environment (Glanz et al.,
2015).
The presence of PD can adversely affect the social capital of the CKD patient due to
bad mouth odor and loss of teeth leading to reduced social interactions. Quality of life
can be affected by poor oral health conditions with resultant pain, dysfunction, and
discomfort from the presence of PD (Baker et al., 2016). The lack of access to basic
dental services and progression of PD due to no treatment produces oral complications
such as dry mouth, bad mouth odor, loose teeth, and bleeding gum tissues (Soroye &
Ayanbadejo, 2016). Failure to address and treat the PD may lead to increased discomfort
and loss of teeth which can impact the ability to chew and digest foods which are
essential in maintaining health but further jeopardizes the nutritional status of the CKD
patient. Mansouri et al., (2017) reported in their study an association between deficient
vitamin D levels and pro-inflammatory cytokines. The results of the study demonstrated
vitamin D was an active component of the inflammation status of the CKD patient.
The presence of PD in the CKD patient who lacks access to dental services is
resigned to dealing with the disease as best as possible which may lead to less social
interaction. Linn and O’Neal (2018) reported poor oral hygiene was associated with CKD
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and ESRD and made the connection between depression and lack of social support. It is
not difficult to fathom a person’s social interaction with others would decline when faced
with poor oral health and loss of teeth. A person’s physical appearance is usually the first
impression others see followed by their smile and facial appearance. Loss of teeth and
bad mouth odor contribute greatly to a person’s smile and facial appearance. This can
cause the patient to be reluctant in engaging in social interactions with individuals who
they are not familiar with further isolating them from their social networks (family and
friends) continuing to increase their depression and anxiety. This resultant behavior is
evidence of the need for increased collaboration between medical and dental health care
providers and better access to dental services.
Definitions
Terms that were used and discussed throughout this study are identified and defined
as follows:
Chronic Kidney Disease (CKD)-when the kidneys fail to function properly and do
not filter the blood in your system as they should. This is a progressive disease which can
result in complete kidney failure.
Health-Related Quality of Life (HRQoL)- this a multi-dimensional concept which
is inclusive of the following determinants: physical, mental, emotional, and social aspects
of a person’s life. It focuses on how a person’s health status impacts their quality of life
which helps to define the person’s overall well-being.
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End-Stage Renal Disease (ESRD)- the complete loss of kidney function which
requires dialysis care or a kidney transplant to survive.
Inflammatory Process – the fundamental response of the body to an injury or a
disease which is most often characterized by signs and symptoms of pain, localized heat
(warm to the touch), redness, and swelling.
Social Capital- this is considered a social determinant of health and a factor
regarding a person’s health outcomes. Social support and social participation are
components of social capital and combined with self-management and health literacy
they become intermediate factors among social determinants and expected health
outcomes. Social capital, self-management, and health literacy have the ability to lessen
the severity of health inequities.
Assumptions
This study was based on two assumptions. These assumptions were (a) the answers
provided by the participants in the 2016 BRFSS were collected and recorded by trained
telephone interviewers hired to perform the survey data collection conducted monthly by
state health departments with a standardized health questionnaire, and methodologic
assistance from the CDC, and (b) that the answers given by the participants were truthful
and honest in the reporting and that the 2016 BRFSS participants’ answers to the survey
questions are given to the best of their knowledge and recollection. These assumptions
were made because the participants’ medical and dental diagnoses could not be
confirmed by clinical records or examination findings.
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Scope and Delimitations
This study addressed participants’ overall health and well-being as recorded by the
variable HRQoL. Participants were 45-64 years old. They were chosen based on their
medical conditions (presence of kidney disease, presence of periodontal disease as
determined by number of teeth extracted because of gum disease) and the presence of
mental health status (number of days of depression since being diagnosed with CKD).
The number of days of depression did not exceed more than 30 days to be included in the
study. The secondary data used in this study was taken from the 2016 BRFSS. This study
did not consider any treatments the participants may have received in analyzing the
results of the study.
Limitations of the Study
This study was limited by the use of secondary data taken from the 2016
Behavioral Risk Factor Surveillance Survey (BRFSS) but did not include additional
survey questions asked in 2017 which were related to diet and nutrition. Populations
used in the study were limited in size and scope by type of questions presented to the
survey participants and the responses received from the participants. Medical treatments
for any existing illnesses or conditions were not considered and thereby may have an
altering effect on the data obtained by the original researchers. It may also affect the
researchers’ conclusions and final reporting. The study was also limited in the response
of the participants not being validated by medical and dental professionals since their
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answers to the survey questions regarding medical/dental diagnoses were not confirmed
by clinical record and or examinations.
Significance of the Study
There was significance in having conducted this study because it broadens the
knowledge in the discipline of collaborative care between medical and dental
professionals. Inclusion of dental care as a primary health care item is important to access
of care and improving health outcomes. This study can have an impact on how health
policies are legislated and applied in public health settings to give people the access they
need to obtain a level of optimal health that manifests overall health. Improved health
outcomes and increased overall health (medical, dental, and mental health status) are a
few of the components of public health. A healthier workforce has an effect on the
socioeconomic status of the population, increased collaborations between medicine and
dentistry increases health literacy, and earlier diagnosis and treatment may lead to
decreased incidence of morbidity and mortality. Treatment options to address
comorbidities such as cardiovascular issues and nutritional deficiencies become fewer
when oral health is neglected. Persons with CKD have been shown to have higher
incidence of hospitalization rates and increased mortality rates with poorer HRQoL
(Gemmell et al., 2016).
The results of this study provide additional information to justify the inclusion and/or
increased coverage of dental care services to adults other than pregnant women. Regular
and preventative dental care services should be available for adult populations receiving
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health care coverage through the Centers for Medicaid/Medicare Services (CMS) to help
decrease the current epidemic of PD taking place in the U.S. and globally as noted in the
Healthy People 2020 report (Varenne, 2015). Currently, individual states decide what
dental care services they will provide under Medicaid/Medicare. Presently, adult pregnant
women are generally covered by Medicaid for dental care (Calvo, Chavez & Jones,
2016). Adding dental care services for all adults could result in a healthier workforce,
increased labor production, and lowered societal economic burden due to improved
health outcomes.
Summary
There has not been enough research exploring the relationship between the
inflammatory processes of systemic diseases such as CKD and PD. There has been
research identifying the inflammatory mediators that are shared by CVD (specifically
atherosclerotic cardiovascular disease) and PD, diabetes mellitus and PD, CKD and PD
but little evidence of how the presence of PD may affect the health outcomes of those
patients experiencing CKD. Predicting health outcomes (HRQoL) is an important
measure that is used to help determine the cost of care for treating and managing chronic
diseases. Increased collaborative efforts between medicine and dentistry can help with
providing earlier diagnosis and treatment interventions leading to a healthier labor force,
decreased cost of care, and improved overall health. Early diagnosis and treatment of PD
of the patient with other chronic inflammatory conditions such as CKD may have a
significant impact on the predicted health outcomes and economic status of the
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population. The following sections will present the design, methodologies, and data
collection used in this study. A random sampling of the secondary data taken from the
2016 BRFSS was used. Analyses and interpretation of the findings were found to be
statistically significant.
Section 2: Research Design and Data Collections
Introduction
The purpose of this study was to determine the existence of a correlation between the
presence of PD in the CKD patient and the predicted outcome (HRQoL) of the CKD
patient. This quantitative, cross-sectional study used secondary data from the 2016
BRFSS that is one of several research surveys used by the CDC to obtain information on
the health status of the adult U.S. population. This chapter will look closely at the
targeted population, the social determinants of health (SDoH) (socioeconomic status,
race, gender, education, income) and existing comorbidities (CVD, diabetes).
Comorbidities are relevant because they have an impact on the HRQoL for the CKD
patient.
Research Design and Rationale
The variables in this study were the independent variable of the presence of PD,
the dependent variable HRQoL, and the confounding variable of poor mental health days.
Also identified in this study are predictor variables of Poor Physical Health
(POORHLTH), kidney disease (CHCKIDNY), and other variables related to HRQoL
such as mental health (MENTHLTH= mental health status not good in the past 30 days)
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and physical health (PHYSHLTH = physical health not good in the past 30 days). The
following variables of CKD, MENTHLTH, POORHLTH, and PD were the variables
primarily used for this study. PD was identified by the variable RVTETH3 (representing
the presence of PD).
The research design for this study included the use of descriptive and
inferential statistical analyses to organize and predict the health behaviors of the targeted
population. Different statistical analyses were used to answer the following research
questions:
RQ (1): Is there a statistical significance in the HRQoL of kidney disease patients
with no presence of PD and the HRQoL of those kidney disease patients presenting with
PD as indicated by loss of teeth?
Correlational analysis was performed to show if such significance exists and if so the
strength of said statistics (Frankfort-Nachmias & Leon-Guerrero, 2018). The hypotheses
for RQ1 were as follows:
H0: There is no statistical significance in the predicted outcome of the HRQoL of
patients diagnosed with both kidney disease and PD and the HRQoL of those patients
only diagnosed with kidney disease.
H1 : There is a statistical significance in the HRQoL of patients diagnosed with
kidney disease and PD and the HRQoL of those patients only diagnosed with kidney
disease.
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The correlational analyses would only account for the presence of chronic kidney disease
(CKD) and its impact on the HRQoL. An additional test of multiple regression would
allow for the presence of another predictor variable. To answer the second research
question the multiple regression analyses test would be needed and this would allow for
another predictor variable to be added.
The second research question is stated as:
RQ2: Is there statistical significance in the outcome of the HRQoL of the CKD
patient diagnosed with PD and less than 30 reported days of depression (mental health)
after being diagnosed with CKD?, with the hypotheses for RQ (2) being :
H02: There is no statistical significance in the outcome of the HRQoL of the CKD
patient diagnosed with PD and less than 30 reported days of depression (mental health)
after being diagnosed with CKD.
H12 : There is a statistical significance in the outcome of the HRQoL of the CKD
patient diagnosed with PD and less than 30 reported days of depression (mental health)
after being diagnosed with CKD.
Use of the multiple regression analyses with the one-way ANOVA (analysis of
variance) gives the researcher the ability to test for significance of difference between the
mean scores of two or more groups across one or more variable. In this study the use of
ANOVA gives the difference between the number of days of mental health not being
good, the presence of PD and CKD, and their impact on the HRQoL of the CKD patient.

33
RQ2 has been answered and supported by the data obtained through the statistical
analyses which were performed using IBM SPSS Statistics 25. Multiple regression
analyses were used to test the effect of the independent variables (e.g., presence of gum
disease-PD, depression- mental health status not good, presence of kidney disease- CKD)
on the value for the dependent variable (HRQoL) of the CKD patient (FrankfortNachmias & Leon-Guerrero, 2018). The targeted population in the 2016 BRFSS dataset
represented those individuals experiencing PD and CKD. This population was chosen
because they represent a large segment of the able-bodied working-class citizens in the
U.S.. All participants were contacted via landline and cell-phone surveys and were
chosen randomly. The research design for this study was aligned with the procedures
used in the social sciences to summarize and tell a story about the data represented by
sets of numbers (Frankfort-Nachmias & Leon-Guerrero, 2018).
Data Collection and Analysis
The data collected in the 2016 BRFSS were analyzed using the IBM Statistical
Package for the Social Sciences (SPSS) Version 25. Correlational testing (bivariate and
partial) was used to answer RQ1: Is there a relationship between the HRQoL(DV) of
participants with kidney disease who also have gum disease (IV) when compared with
those participants with kidney disease and no gum disease? The correlation test was to
determine if a relationship existed between two variables where in this study the HRQoL
is the dependent variable (DV) and the gum disease is the independent, or predictor
variable (IV). Regression analysis (multiple linear) was used to answer the RQ2: Is there
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a difference in the HRQoL of the participants with kidney disease, no gum disease
present and has reported days of depression and those participants with kidney disease,
gum disease present and less than 30 reported days of depression after being diagnosed
with CKD? Regression analysis was performed because it was the most correct method to
answer the RQ2 since there are more than one predictor variables (gum disease and days
of depression) and one dependent variable (HRQoL).

Methodology
The data in the 2016 BRFSS database was viewed to determine the presence of all of
the identified variables needed to conduct this study. All of the necessary variables were
present in the database and it was decided to pursue the study with said variables. A
smaller dataset consisting of a 20% random sampling (N = 96,787) was created from the
larger database (N = 486,303) to make it simpler to run the analyses. The random
probability sampling was performed using the IBM SPSS Version 25 by taking 20% of
the original dataset. Each question in the survey which was pertinent to the research
questions were highlighted and checked for use in the statistical analyses. The larger and
original dataset (BRFSS 2016) was used which provided data collected from each of the
50 U.S. states including the District of Columbia and the three (3) U.S. territories.
Information from the 2016 BRFSS was published in October 2018 and was made
available through the CDC website using the search term BRFSS. The survey was
performed by trained interviewers who coded and reported answers from the survey
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participants. The data collection took place via landline and cell phone between January
and December 2016. Survey participants were randomly recruited by telephone with
respondents’ age having to be at least 18 years. The random sample which was chosen as
20% has a standard deviation almost equal to that of the larger data set which results in
an effect size that is relatively small. Table 1 displays the group statistics of those chosen
for the target population of this study and the results of the Independent Samples t test (in
Table 2) displays the results from which the effect size can be calculated. The effect size
was calculated by using the equation of the mean of both the sample size and the larger
data set divided by the standard deviation (assuming the SD of both sample and larger
data set are equal). The resulting effect size is small (0-.20). The alpha level (α) was
chosen at .05 with a confidence interval (CI) of 95% and p < 0.05. All of the survey
responses were accepted as being valid and generalizable. These results are demonstrated
by the use of the Independent-Samples t test as displayed in Table 2 and the following
equation determining Cohen’s d which identifies effect size (0-.20 = small effect size,
0.50 = medium, 0.80 = large).
To understand the analysis the focus is on the second row of the test where the t =
3.519 and the value of the df (degrees of difference between the two groups) = 1825.379.
The analysis does show significance at the level of .000. The equation to determine
Cohen’s d is as follows: 2 x 3.519/ √1825.379 = 0.0077, calculating for a small effect
size.
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Table 1

T-Test
Group Statistics
NUMBER OF
PERMANENT TEETH
REMOVED
NUMBER OF DAYS
PHYSICAL HEALTH
NOT GOOD
(EVER TOLD) YOU
HAVE KIDNEY
DISEASE?

N

Mean

Std.
Deviation

Std. Error
Mean

1

29483

59.91

37.357

.218

2

12331

53.50

36.876

.332

1

29483

1.98

.331

.002

2

12331

1.96

.446

.004

Table 2- Independent Samples Test
Independent Samples Test
Levene's Test
for Equality of
Variances

t-test for Equality of Means
95% Confidence Interval of the

Sig.

F
NUMBER OF DAYS

Equal variances

PHYSICAL HEALTH

assumed

NOT GOOD

Equal variances

Sig.

19.958

t

.000 16.072

df

(2-

Mean

Std. Error

tailed)

Difference

Difference

Difference
Lower

Upper

41812

.000

6.415

.399

5.632

7.197

16.158 23384.088

.000

6.415

.397

5.637

7.193

.000

.016

.004

.008

.023

not assumed
Equal variances
assumed

198.07
8

.000

3.967

41812
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(EVER TOLD) YOU

Equal variances

HAVE KIDNEY

not assumed

3.519 18245.379

.000

.016

.004

.007

DISEASE?

Because of the small effect size, it can be concluded that there is none or at least,
truly little probability of there being a Type II or β error among the sample size taken
from the larger population and that there is generalizability in this study. With the effect
size being so small then the study can be said to have enough power to reject the null
hypotheses and accept the hypotheses that the presence of PD (Number of Permanent
Teeth Removed or RMVTETH) can and does have an impact on the HRQoL of the CKD
patient. The additional variable of mental health status not being good (MENTHLTH)
also contribute to the HRQoL of the CKD patient and has a measurable effect on the
predicted outcome of the HRQoL.
Population
The demographics of the target population (N = 96,787) are persons between the ages
of 45-64 years (both males and females), diagnosed with CKD and not diagnosed with
CKD, have lost teeth due to gum disease, and have days of mental health issues fewer
than 30 days after being diagnosed with CKD. The total participants were selected
through a random probability sampling from the secondary data set of the 2016 BRFSS.
Race/ethnicity, socioeconomic status, education, and income levels were not computed as
part of the variables in this study.

.024
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Sampling & Sampling Procedures
Inclusion criteria for the participants in this study had to adhere to the following
guidelines:
1. All participants (male and female) regardless of gender or race
2. Must be between the ages of 45-64 years old
3. Each participant selected would have been told they have kidney disease and
have had a minimum of three teeth or more extracted due to gum disease
4. Have responded to the survey question asking the number of days of depression
within the past 30 days
5. Responded to the survey question asking their self-reported health status (i.e.,
poor, fair, good, excellent) which is representative of their HRQoL.
Participants were excluded from this study if they meet these criteria:
1. Were not between the ages of 45-64 years old
2. Have not been told they have kidney disease
3. Have not been told they have either chronic condition (kidney disease or gum
disease)
4. Have not had any teeth extracted because of gum disease
Data Analysis Plan
The data collected in the 2016 BRFSS was analyzed using the IBM Statistical
Package for the Social Sciences (SPSS) Version 25. Correlational testing (bivariate and
partial) was used to answer RQ1: Is there a relationship between the HRQoL(DV) of
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participants with kidney disease who also have gum disease (IV) when compared with
those participants with kidney disease and no gum disease? The correlation test was to
determine if a relationship existed between two variables where in this study the HRQoL
is the dependent variable (DV) and the gum disease is the independent, or predictor
variable (IV). Regression analysis (multiple linear) and one-way ANOVA testing was
used to answer the RQ2: Is there a difference in the HRQoL of the participants with
kidney disease, no gum disease present and has less than 30 reported days of depression
and those participants with kidney disease, gum disease present and less than 30 reported
days of depression after being diagnosed with CKD? Regression analysis and ANOVA
were performed because they were the most correct method to answer the RQ2 since
there are more than one predictor variables (gum disease and days of depression) and one
dependent variable (HRQoL). The CI of 95% and the probability value, p < 0.05, will be
used to interpret the results of the findings.
Threats to Validity
The threat to internal validity may occur due to responses from the survey
participants which are not truthful and cannot be verified or confirmed as such. The
measurement of the extent of the PD is predicated upon the number of lost teeth due to
gum disease as was told to the survey participant by a dental professional. The level of
severity of PD will not be assessed based on the number of lost teeth but only indicated
as being present. The sample size of the participants responding to the 2016 BRFSS can
be identified as representative of the population at large as this survey is the largest
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survey system worldwide and is considered a standard in tracking behavioral health
(www.cdc.gov/brfss). Therefore, the results of the study were viewed as generalizable
with no threat to external validity. The Institutional Review Board (IRB) approved the
use of the data set for this study confirming that the collection of the data met all ethical
standards. The approval number for this study is 06-17-20-0693980.
Summary
Section 3: Results and Findings
Introduction
The purpose of this study was to determine if there is statistical significance in the
presence of PD on the outcome of the HRQoL for the CKD patient. The research
questions are:
RQ1: Is there a statistical significance in the HRQoL of kidney disease patients
with no presence of PD and the HRQoL of those kidney disease patients presenting with
PD as indicated by loss of teeth?
H0: There is no statistical significance in the predicted outcome of the HRQoL of
patients diagnosed with both kidney disease and PD and the HRQoL of those patients
only diagnosed with kidney disease.
H1 : There is a statistical significance in the HRQoL of patients diagnosed with
kidney disease and PD and the HRQoL of those patients only diagnosed with kidney
disease.
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RQ (2): Is there statistical significance in the outcome of the HRQoL of the CKD
patient diagnosed with PD and reported days of depression (mental health) over a 30-day
period?, with the hypotheses for RQ (2) being :
H02: There is no statistical significance in the outcome of the HRQoL of the CKD
patient diagnosed with PD and reported days of depression (mental health) over a 30-day
period.
H12 : There is a statistical significance in the outcome of the HRQoL of the CKD
patient diagnosed with PD and reported days of depression (mental health) over a 30-day
period.
The study topic addressed the statistical significance of the presence of PD on the
days and when there are no challenges of less-than-optimal mental health days over a 30day period. Less than optimal mental health days that are more than 30 days would
suggest the patient needs a mental health screening for depression and/or mental health
conditions. This section will present the results of the statistical analyses used to test the
hypotheses, provide the demographics and descriptive statistics of the sample population
and its’ relation to the larger data set, and analyze the findings of the statistical analyses
utilized with the presentation of tables produced by the tests results.
Data Collection of Secondary Data Set
Data for this study was taken from the 2016 BRFSS. The 2016 BRFSS
(Behavioral Risk Factor Surveillance Survey) is the largest health behaviors survey
conducted continually by the Centers for Disease Control and Prevention since its
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inception in 1984. The survey is conducted and data collected from all 50 US states, the
District of Columbia, and the three US territories with over 400,000 interviews completed
yearly by trained interviewers. Data was entered into the BRFSS dataset using the
Ci3WinCATI data entry module software. The data was collected from January December 2016 and the results were published in August 2017 via both landline and cell
phone usage. Survey participants had to be a minimum age of 18 years with no other
specific criteria for inclusion in the survey. The response rates of the participants for both
landline and cell phones were as follows: mean = 46.7%, median = 47.1%, maximum=
65%, and a minimum = 30.7%. There were no discrepancies in the intended and planned
use of the results of the 2016 BRFSS.
Baseline descriptive and demographic characteristics of the survey participants
for this study showed that the 43.31% were males and 56.68% were females with a
majority of the population identified as Black. Educational levels were a high school
diploma or GED, and average maximum income at $20,000, and a 4% rate of
unemployment for one year or more. The tables shown demonstrate that the majority of
the sample population may be considered to have low socioeconomic status and more
likely to be unemployed once the medical condition has been diagnosed. Educational
level may also be a factor in the medical/oral health literacy of the sample population in
this study and may account for the lack of early diagnosis and treatment of both CKD and
PD. The descriptive statistics (age, gender, race) of the probability sample of participants
(N = 96,787) is shown in Table 3. Other descriptive statistics for income level, education,
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race, and employment status are displayed in Table 4 along with the value assigned as
expressed in the BRFSS codebook.

Table 3 Demographics – Age, Sex
Descriptive Statistics
RESPONDENT

Age

45-64

S SEX

Valid

35558

96787

Missing

61229

0

Mean

2.7017

1.57

Median

3.0000

2.00

1.09245

.503

Std. Deviation

Male = 1

Female = 2

Table 4 Demographics (Race, Income, Employment, Education)

Descriptive Statistics
N

Minimum

Maximum

Mean

Std. Deviation

EDUCATION LEVEL

96786

1

9

4.91

1.074

INCOME LEVEL

96015

1

99

19.15

30.892

EMPLOYMENT STATUS

96773

1

9

3.96

2.881

COMPUTED RACE-

96787

1

9

2.04

2.291

ETHNICITY GROUPING
Valid N (listwise)

96012

(BRFSS Codebook Values for the demographics can be found in the appendix)
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The characteristics of this sample also represent those persons who meet the study
criteria of being between the ages of 45-64 years, have been diagnosed with kidney
disease, and have had at least three permanent teeth extracted. PD is represented by the
removal of at least three permanent teeth. A diagnosis of PD was not characterized by the
survey’s respondents and the removal of at least three permanent teeth is more likely to
be a result of the identification PD being present. The sample population used for this
study is a probability sampling and is representative of the total population surveyed in
the 2016 BRFSS. A 20% random sampling was chosen instead of a 10% because of the
large size of the secondary dataset that was used. The random sampling (N= 96.787) is
proportional to the total survey participants (N=486,303) and therefore the results of the
findings would be generalizable. There were no covariates used in this study only the
dependent variable of HRQoL and the independent variables of PD (represented by
Number of Permanent Teeth Removed or RMVTETH3) and MENTHLTH (related to
HRQoL).
Results
The statistical tests performed in this study were the correlational analysis, multiple
regression and one- way ANOVA, and the independent samples test. In the following
tables all of the results of the statistical tests will be displayed. Results will be interpreted
using the CI of 95% and a probability value of p < 0. The effect size has been calculated
as small but will still have an impact on the population at large in reference to the costs of
care and expected decrease in hospitalization rates, mortality, and morbidity rates.
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RQ1: Is there statistical significance in the HRQoL of patients diagnosed with
kidney disease and PD and the HRQoL of those patients only diagnosed with kidney
disease?
H0: There is no statistical significance in the predicted outcome of the HRQoL of
patients diagnosed with both kidney disease and PD and the HRQoL of those patients
only diagnosed with kidney disease.
H1 : There is a statistical significance in the HRQoL of patients diagnosed with
kidney disease and PD and the HRQoL of those patients only diagnosed with kidney
disease.
Correlational testing was done and showed a significance at the .000 level which
identifies that there is a difference in the presence of PD on the outcome of the HRQoL
of the CKD patient. RQ1 refers to whether there is a difference when there is PD present
in the patent diagnosed with CKD as opposed to those patients who have only been
diagnosed with CKD. The results of the correlational analysis in Table 5 clearly shows
the Pearson’s correlation at .033 when PD is present and a correlation at .035 (Table 5)
when there is no presence of PD. Although the difference may appear small it is still
significant when looking at the difference statistically. Because of these results the null
hypotheses of RQ1 can be rejected and the accept the H1 of RQ1. The RQ1 is addressed
and answered by the results of the correlational testing showing a statistical significance
present when PD has been diagnosed in the CKD patient thereby the null hypotheses can
be rejected. Table 5 shows the correlational analysis test identifying a relationship
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between the presence of PD and kidney disease. There is a statistical significance of .000
where correlational significance is shown at the 0.01 level. The probability value
associated with this analysis is p < 0.05 and the level shown is lower than 0.05.

Table 5 Correlational Analysis

Correlations
NUMBER OF

NUMBER OF DAYS

Pearson Correlation

PHYSICAL HEALTH NOT

Sig. (2-tailed)

GOOD

N

(EVER TOLD) YOU HAVE

Pearson Correlation

KIDNEY DISEASE?

Sig. (2-tailed)
N

DAYS

(EVER TOLD)

PHYSICAL

YOU HAVE

HEALTH NOT

KIDNEY

GOOD

DISEASE?
1

.035**
.000

96787

96787

.035**

1

.000
96787

96787

**. Correlation is significant at the 0.01 level (2-tailed).

Comparison of the results from Tables 5 & 6 show a difference between the
presence of PD in CKD patients and those diagnosed with CKD but no PD. Examination
of the statistics in Table 5 endorses the rejection of the null hypothesis and supports the
proposed theory that the presence of PD in CKD patients does have an adverse effect on
the HRQoL for the CKD patient.
Table 6 displays a correlation in the partial correlation analysis between the
presence of PD and reduced number of reported days of physical health not being good.
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The variable (PHYSHLTH) is representative of the HRQoL of the CKD patient and is
specific to the age group (45-64 years) of the target population. The independent variable
of PD was added to the correlational analysis to see if there was a statistical difference
when the CKD patient had PD present and what difference, if any, this would have on the
HRQoL of the CKD patient. In Table 4 the results show there was a statistical difference
when PD was present albeit was small there is still a statistically significant difference
and it had an effect on the HRQoL.

Table 6 Correlational Analysis

Partial Corr

Correlations
(EVER TOLD)

Control Variables
NUMBER OF PERMANENT

(EVER TOLD) YOU HAVE

Correlation

TEETH REMOVED

KIDNEY DISEASE?

Significance (2-

YOU HAVE

NUMBER OF DAYS

KIDNEY

PHYSICAL HEALTH

DISEASE?

NOT GOOD

1.000

.033

.

.000

0

96784

tailed)
df
NUMBER OF DAYS

Correlation

.033

1.000

PHYSICAL HEALTH NOT

Significance (2-

.000

.

GOOD

tailed)
96784

0

df
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This partial correlational analysis shows the relationship between the presence of kidney
disease and the number of days of physical health (PHYSHLTH) that is not considered
good. The variable PHYSHLTH is representative of the HRQoL of the CKD patient and
is important in measuring the overall health outcome of the patient in relation to their
hospitalization rates and cost of care. The result of the analysis shows significance as
displayed in Table 5 at the level of .000 which is lower than the p value of 0.01 where p <
0.05 and the statistical evidence presented here bears that out. Pearson’s correlation has
been calculated at 1 which shows a strong correlation between the variables of the
presence of PD and poor physical health (representative of the HRQoL) of the CKD
patient.
The RQ2: Is there statistical significance in the outcome of the HRQoL of the CKD
patient diagnosed with PD and reported days of depression (mental health) over a 30-day
period?, with the hypotheses for RQ (2) being:
H02: There is no statistical significance in the outcome of the HRQoL of the CKD
patient diagnosed with PD and reported days of depression (mental health) over a 30-day
period.
H12 : There is a statistical significance in the outcome of the HRQoL of the CKD
patient diagnosed with PD and reported days of depression (mental health) over a 30-day
period.
To answer the RQ2 the statistical test of regression analysis was utilized and the results
are presented in Tables 7-9. In Table 7 the independent variables of PD (represented by
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Number of Permanent Teeth Removed or RMVTETH3) and reported days of depression
over a 30- day period (represented by Number of Days Mental Health Not Good) are
entered as predictor variables. The dependent variable of PHYSHLTH (representative of
HRQoL) is entered to predict whether or not it is affected by the presence of the
independent variables, Number of Permanent Teeth Removed or RMVTETH3, and
Number of Days Mental Health Not Good and to what extent is there significance.

Table 7
Regression Analysis
Variables Entered/Removed
Model
1

Variables

Variables

Entered

Removed

NUMBER OF

Method
. Enter

PERMANENT
TEETH
REMOVED,
NUMBER OF
DAYS MENTAL
HEALTH NOT
GOOD, (EVER
TOLD) YOU
HAVE KIDNEY
DISEASE?b
a. Dependent Variable: NUMBER OF DAYS PHYSICAL
HEALTH NOT GOOD
b. All requested variables entered.

Table 7 shows the variables which were entered for the analysis and Tables 8 & 9
display the results of the multiple linear regression analysis and the level of significance.
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Regression analysis shows the predictability of the outcome that exists as a result of the
relationship between the variables. This analysis allows a prediction about the outcome of
the HRQoL of the CKD patient based on its relationship to the variables that were
entered in Table 7 (MENTHLTH, PD, and CKD). The results in Table 8 displays the
correlation coefficient (Pearson’s r) and the PRE (prediction errors) which is the R
square. The results show that for every 6.8% variation in the number of days the physical
health is not good (PHYSHLTH) it can be attributed to the presence of PD and
MENTHLTH, thereby affecting the HRQoL of the CKD patient. These results
definitively answer RQ2 by presenting evidence that there is a statistical significance in
the outcome of the HRQoL of the CKD patient when PD is present.
The discussion relating to the presence of PD is important and is all the more relevant
when viewing the results of the ANOVA (analysis of variance) test in Tables 8 & 9. The
values show a significance at the .000 level and clearly supports the rejection of the null
hypothesis for RQ2. A 6.8% difference in the variability of the HRQoL that can be
attributed to the presence of PD is significant enough and the statistical analysis shows
that to be true supporting the alternative hypothesis and rejecting the null.

Table 8
Model Summary
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Model

R

1

.261a

R Square

Adjusted R

Std. Error of the

Square

Estimate

.068

.068

35.768

a. Predictors: (Constant), NUMBER OF PERMANENT TEETH
REMOVED, NUMBER OF DAYS MENTAL HEALTH NOT GOOD,
(EVER TOLD) YOU HAVE KIDNEY DISEASE?

In Table 9 below, the significance is shown to be at the .000 level which is also lower
than the p <0.05 value. Both tables display that there is significance at the .000 levels as
demonstrated in the results of the multiple linear regression and ANOVA analyses. This
analysis of variance (ANOVA) allows for the comparison of independent variables (PD
and Number of days Mental Health Not Good) with a dependent variable (CKD patient).
This analysis will test for any significance of comparison of variance between the two
groups with variance within the groups (Frankfort-Nachmias & Leon-Guerrero, 2018).
The results show a significance at the .000 level which is below the chosen p value of
0.05. None of the research previously identified in this study showed a correlation
between the presence of PD, mental health status, and HRQoL for the CKD patients. The
focus of this study was to identify a correlation between the aforementioned variables and
demonstrate the association between the presence of PD and decreased HRQoL of the
CKD patient.
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Table 9
ANOVAa
Model
1

Sum of Squares
Regression

Df

Mean Square

9049135.787

3

3016378.596

Residual

123818331.667

96783

1279.340

Total

132867467.453

96786

F
2357.762

Sig.
.000b

a. Dependent Variable: NUMBER OF DAYS PHYSICAL HEALTH NOT GOOD
b. Predictors: (Constant), NUMBER OF PERMANENT TEETH REMOVED, NUMBER OF DAYS
MENTAL HEALTH NOT GOOD, (EVER TOLD) YOU HAVE KIDNEY DISEASE?

In Table 10 below, the same information is given after completing the analysis showing
that the HRQoL (PHYSHLTH) of the CKD patient is affected by mental status (2.54%)
and the presence of PD (8.98%), showing a significance for both variables with p =.000
(which is below the 0.05 chosen p value). The results of this analysis also demonstrate
there is a statistically significant difference when the variable of mental health not being
good is added as a predictor variable in the outcome of the HRQoL of the CKD patient.
This result allows for the rejection of the null hypothesis and acceptance of the
alternative.
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Table 10
Coefficientsa
Standardized
Unstandardized Coefficients
Model
1

B
(Constant)
NUMBER OF DAYS

Coefficients

Std. Error

33.618

.704

.254

.003

3.204

.898

Beta

t

Sig.

47.762

.000

.247

79.566

.000

.328

.030

9.783

.000

.035

.079

25.433

.000

MENTAL HEALTH NOT
GOOD
(EVER TOLD) YOU HAVE
KIDNEY DISEASE?
NUMBER OF PERMANENT
TEETH REMOVED
a. Dependent Variable: NUMBER OF DAYS PHYSICAL HEALTH NOT GOOD

As with any statistical testing, the effect size is important in establishing if there is a
real difference between the sample size and the target population. Tables 9 & 10 above
display the T-test and an Independent Samples Test. These tests were done to determine
the probability that the sample population is representative of the larger population that
was surveyed in the 2016 BRFSS and was chosen independently from normal
populations (those persons who meet the criteria for inclusion in this study). The tests
also allow the researcher to determine what the effect size would be and what, if any
significance would be shown. The independent samples test shows significance at .000
determining there is an exceedingly small effect size and no difference across the groups
when comparing the means of the variables indicated. There is significance shown in the
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test results at the .000 level in Table 10 and therefore it can be assumed that the sample
population is representative of the larger population surveyed.
Summary
The preceding results of the statistical analyses that were performed definitively
showed a correlation between the presence of PD in the CKD providing a basis for the
hypotheses of PD affecting the HQRoL of the CKD patient. All of the analyses that were
performed showed a level of significance (p < 0.05) in the correlation between the
presence of PD and the effect on the HRQoL of the CKD patient. The results of the
analyses displayed supportive evidence of rejecting the null hypotheses and accepting the
stated theory that PD does in fact alter the HRQoL of the CKD patient. The analyses
examining the additional variable of mental health status also demonstrated an effect on
the HRQoL as well as the presence of PD. There can be no mistake that the addition of
poor mental health status has a negative effect on the predicted outcome of the HRQoL of
the CKD patient as seen in the statistical evidence provided. The HRQoL is further
compromised and decreased with the addition of poor mental health status is added as a
factor in predicting health outcomes. Both PD and poor mental health status have a
negative effect for the predicted outcome of the HRQoL of the CKD patient and that does
affect hospitalization, morbidity and mortality rates, and the overall cost of care. The
stated research questions and hypotheses were indeed supported and accepted by the
results of the statistical analyses performed.
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Section 4: Application to Professional Practice and Implications for Social Change
Introduction
Is there any statistical significance in the presence of PD and its relative impact on
the HRQoL for the CD patient and if so, is that significance further advanced by the
presence of a poor mental health status for that same patient? In both research questions
the null hypotheses can be rejected because of the supportive evidence provided by the
results of the statistical tests performed. This study was done to offer additional evidence
showing a correlation between PD and CKD and how PD can affect and have an impact
on the HRQoL for the CKD patient. The literature review conducted for this study did not
provide any relevant and current information on the impact of PD and its’ effect on the
HRQoL of the CKD patient. Previous studies (Kiany et al., 2013; Bandal, Pandey &
Asthana, 2014; Sharma et al., 2017) have shown that early diagnosis and treatment of PD
can decrease the levels of the inflammatory markers which have been identified as being
present in both CKD and PD. Controlling and/or reduction of inflammatory mediators
has a positive impact by reducing morbidity and mortality rates in the CKD patient
(Sharma et al., 2017). A reduction in mortality/morbidity rates coincide with a reduction
in hospitalization rates, decreased costs of care, and increased positive patient outcomes.
Nguyen et al. (2018) reported a clear and consistent association between the severity of
the CKD and the HRQoL of the CKD patient. Their findings were consistent with
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previous research and studies centered around the link between HRQoL and the disease
progression of the CKD patient.
Interpretation of the Findings
The results of the statistical analyses that were performed, multiple linear regression
and correlation), demonstrated a significance in the hypothesized relationship between
PD and CKD when examining the inflammatory processes present in both diseases. The
presence of oral health diseases can adversely affect the quality of life producing pain,
lack of interest in self-care because of oral dysfunction and discomfort exacerbated by the
presence of PD (Baker et al, 2016). In studies conducted by French et al, (2018) the
results clearly show that PD is a major causative factor in tooth loss while demonstrating
that there is a correlation between the presence of PD and other systemic inflammatory
conditions. This study result was supported by a NHANES (National Health And
Nutritional Examination Survey) study reporting 47% of adults over age 30 experience a
form of PD. This same age group is a small portion which is representative of the target
population chosen for this study. The target population (ages 45-64 years) in this study
accounts for approximately 13% of the total US population (www.cia.gov/library) and of
this total the incidence rate of CKD is 10.4 per 1,000 persons (www.nccd.cdc.gov/ckd)
and estimates that 17% of all US adults within the target population have been diagnosed
with CKD. Severe PD affects 14% of adults ages 45-64 years (www.cdc.faststats).
In the correlational tests (refer to Table 6) where the results show that the presence
of PD and mental health status not being good account for a 6.8% change in the outcome
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related to HRQoL for the CKD patient. These results show a definite correlation between
the presence of PD and the manifestation of a less than optimal mental health status. The
outcome of the analyses performed demonstrate that the HRQoL can be predicted by the
occurrence of the variables of PD and mental health status. In an earlier study the
prevalence of depression in CKD patients was shown to range from 21.4% - 39.3%, and
negatively impacted the quality of life for the CKD patient leading to increased
hospitalization, morbidity, and mortality rates (Schick-Makaroff et al, 2018) further
supporting the results of the analysis shown in Table 8. The presence of decreased mental
health status (depression) is a common denominator among CKD patients with an
estimated 25-50% of those patients reporting depressed mental health status (Siou-Hung
Tsai et al., 2015) and in a subsequent study by Jhee et al. (2017) depression was reported
to be the most common psychological factor among KD patients. Review of previous
studies examining the effect of depressed rates of mental health status on CKD patients
(Schick-Makaroff et al, 2018, Siou-Hung Tsai et al, 2015) reveal a distinct commonality
in the presence of depression among CKD patients with negative impact on quality of life
for these patients. In the study by Siou-Hung Tsai et al (2015) the results showed a
marked increase in proinflammatory cytokines, reduction of serum albumin concentration
(affects body tissue repair, chronic inflammation is a causative factor), and an association
between depression and malnutrition in the CKD patient specifically. The results of the
regression analysis support the results of this study and those of the study conducted by
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Gemmell et al, (2016). This particular study reported that poor HRQL has a propensity to
be much lower in the CKD patient with increased hospitalization and mortality rates.
Most often the CKD patient reports a low adherence to medications and dietary
guidelines as recommended by their health care providers. Depression as well as anxiety
were found to be common in CKD patients than in the general population leading to
lower non-compliance with treatment, increased hospitalizations, mortality and morbidity
rates, and decreased quality of life (Yucens et al., 2019). It is not surprising to find that a
patient’s depressive state of mind has a large impact on how much attention the patient
gives to the management of the disease process and the declining interest in being an
active participant in self-care (Wang et al., 2019).
The HRQoL is an important and measurable variable that is utilized to account
for costs of care, predicting health outcomes, and making evidence-based decisions for
management of the disease process (Wang et al., 2019).
Maravalan et al. (2017) identified socioeconomic, educational attainment, and
income levels as heavy influencers in determining the outcome of the HRQoL of the
CKD patient. Lack of access to care (both medical and dental) and not receiving early
diagnosis to help prevent/retard the progression of disease, play an important role in
whether or not the CKD patient is at an increased risk of PD (Kim et al, 2017). Oral
disease has been noted as the ‘silent killer’ amongst adults in the US (Satcher &
Nottingham, 2017) and oral conditions such as PD can adversely affect the CKD patient’s
quality of life resulting in pain, discomfort as a daily occurrence, (Broadbent et al, 2016)
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and allow the CKD patient to feel a loss of control over their health. Referring to the SCT
framework described as one of the theoretical foundations of this study, the CKD patient
needs to have a sense of control which will allow for improved health outcomes by
increased self-management of their disease conditions.
Patients with CKD are more likely to show a less than desirable HRQoL when
compared with the general population. Studies by Nowak & Choncol (2018) and Nguyen
et al. (2018) both found that CKD patients are a higher risk of decreased HRQoL as the
severity of the inflammation associated with the disease increases. PD is a low-grade
chronic inflammatory process which has been shown to have an association with CKD.
This association has been studied by Grubbs et al. (2016) where the pathogens found in
PD enter the bloodstream and can induce kidney dysfunction via triggering the immune
system’s response to inflammation and initiating a cascade of inflammatory mediators.
Evidence supporting PD pathogens being present and active in atherosclerotic
cardiovascular disease has been stated (Nazir, 2017) in addition to studies revealing
prevalence rates (29-64%) of PD in CKD patients when compared to patients not
diagnosed with CKD (Araujo et al, 2015). The discussion relating to the presence of PD
is important and is all the more relevant when viewing the results of the ANOVA
(analysis of variance) test in Tables 8 & 9.
Support for the interpretation of the findings produced by the analyses can be found
in the study by Tasmoc et al. (2017). In this study the CKD patients had a higher
prevalence of PD than those patients without kidney disease. Studies by Mihai et al.
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(2018) and Tasdemir et al. (2018) identified PD as a low-grade inflammatory process and
a hallmark of CKD, involved in the development of all-cause mortality. Both studies
recognized this type of inflammation as being a central part of the progression of kidney
disease. Inflammation and oxidative stress were also shown to be linked as prominent
characteristics of CKD in a study by Sharma et al. (2017). The study demonstrated that
both CKD and PD share the same inflammatory biomarkers of TNF-α, IL-6, and
increased levels of CRP. The increased levels of CRP and IL-6 support evidence of how
the periodontal inflammatory processes exacerbate the systemic burden via the acutephase and oxidative stress pathways.
Previous studies by Nowak & Choncol, (2018) showed evidence of a relationship
between inflammation in chronic dialysis patients and adverse clinical outcomes. This
study and others (Toraz et al., 2014; Grubbs et al, 2016) continued to press the issue of
how the presence of inflammation adversely impacts the health outcomes for the CKD
patient. The studies also reiterate the message of controlling and reducing the
inflammatory mediators to reduce and/or eliminate the inflammation that leads to
continued dysfunction and impairment of the affected organs. Tasdemir et al. (2018)
concluded in their study that chronic inflammation is a risk factor for the CKD patient
and that the presence of PD in the CKD patient is a source of such chronic inflammation.
This same study also indicated that the TNF-α cytokines which are associated with the
severity of inflammation are reduced once periodontal therapy for PD has been
completed. This information continues to support the evidence of an association between
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the presence of PD and chronic systemic inflammatory conditions. The studies that were
presented and discussed here provide and support evidence of the need for collaboration
between the medical and dental professions. Particular attention should be paid to
reviewing blood pressure and other vital signs as it relates to the presence of systemic
conditions. Patients should be screened on a regular basis for chronic systemic conditions
whether they are being treated by a medical or dental professional. PD affects a large
portion of the population and has been identified as being the common factor in CKD
patients (Kim et al. 2017). This association between PD and CKD patients should be
enough to signal to health care providers to screen patients for systemic conditions
regularly. According to the World Health Organization (WHO) edentulism is seen as a
poor health outcome affecting both oral and general health status including a negative
effect on the quality of life (Hewlett et al, 2015). PD is the major cause of tooth loss
(French et al, 2018) and has a major impact on the social well-being of the patient. The
close association between the presence of PD and CKD indicates that early treatment of
PD could be a method of reducing the risk of the progression of CKD because PD is
preventable with treatment options that demonstrate a reduction in the pathogens causing
continued inflammation (Grubbs et al, 2016). Increased collaborative efforts can only
enhance the patients’ health care and provide the patient with a true sense of being treated
as ‘whole’. Collaborative health care can be the difference between early diagnosis and
treatment and late intervention due to late diagnosis resulting in less than optimal health
outcomes.
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For many patients, a diagnosis of a chronic condition can be both devastating and
paralyzing. Depending on what the prognosis is a patient can find themselves in a state of
uncertainty not knowing how the disease will affect them, how are they going to move
forward, and will their life be forever changed and if so, to what extent? The health care
provider is the person who can assist the patient in navigating the pathways to extend or
maintain an optimum health status. The patient’s prognosis is tied to when they receive
the diagnosis (early or late), extent or severity of the disease/condition, and whether or
not the patient is ready to partner with their health care provider in deciding on treatment
options. When a patient becomes depressed or despondent about their health status then it
becomes more difficult to improve that patient’s overall well-being. Depression and lack
of self-efficacy affects the patients’ HRQoL on several different levels. The concept of
HRQoL is multidimensional consisting of a patent’s perception of how they are
functioning in relation to their physical, psychological, and social well-being (Gemmell
et al., 2016). Studies by Siou-Hung Tsai et al.(2015), and Schick-Makaroff et al.(2018)
have concluded that depression and lack of self-efficacy negatively impact clinical
outcomes and leads to increased hospitalizations, mortality and morbidity rates and
poorer quality of life for the patient.
Relating self-efficacy to the SCT framework provided in this study shows a direct
connection to how improving the CKD patient’s self-management of their condition can
improve their health outcome. In a study by Havas, Douglas & Bonner (2018) the authors
concluded that when the patient displays effective self-management of their disease state
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by adhering to dietary and nutritional guidelines, taking medications as directed, and
cessation of smoking, then their health outcomes are positively impacted. The patient
changes their health behaviors and signals a change in their perception of how much
control they do have in managing their health.
One of the constructs in the framework provided in this study is social capital.
Social capital is considered one of several different social determinants of health and is
viewed as a factor in determining health outcomes (Coll-Planas et al., 2018). When a
patient believes their health is good, have stable oral health (absence of disease), and
believe they are in control of their overall health, their participation in social networks
increases. The patient’s participation in a social network provides an opportunity for the
psychosocial mechanisms of trust, support, and increased self-efficacy which in the end
has an impact on their health (Lee & Jung, 2018). Increased participation of the patient
in social networks and organizations (i.e., family networks, circle of friends) can and
does influence health behaviors (Wong et al., 2018). Social support for improved health
and a positive change in health behaviors are part of the psychosocial construct that is
identified in the SCT framework in this study. The CKD patient’s personal satisfaction
with his/her health and life is overshadowed by their perception of how much control
they have over the physical symptoms of the disease (Kafkia Vehvilainen-Julkunen &
Sapountzi-Krepia, 2017).
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Limitations of the Study
The random sampling taken from the larger data set does not present any
limitations to generalizability to the larger population. The survey data that was collected
was done through trained interviewers and the surveys were conducted the same with all
interviewers. The validity of the study is based on the fact that these surveys are
conducted on a yearly basis throughout the US. It is assumed that the answers which were
given by the respondents to the questions were truthful and valid as there was no
opportunity to perform physical and dental examinations on each person nor were mental
health assessments completed except to ask the respondent how they felt their mental
health status was at the time of the survey. The secondary data set (2016 BRFSS) is
considered to be trustworthy, reliable, and valid.

Recommendations
One particularly important aspect of patient involvement in their care/treatment plan
is the patient’s ability to understand the diagnosis and how it is communicated from the
provider to the patient (Abelsson et al., 2020). Early intervention is essential in slowing
disease progression and giving the health care provider a number of treatment options
that may not have been available if the diagnosis was made late in the disease
progression. This early intervention can be a product of routine health care visits to the
patient’s medical and/or dental provider. Regular visits to a health care provider can
establish better communication and trust between the provider and the patient, increase
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patient health literacy and involve the patient as a partner in determining their health
trajectory (Pinheiro, Zagar & Reeve, 2017). The medical profession needs to be more
involved by simply performing a cursory oral exam as part of their general health exam
to determine if there is a need for dental care. This can result in early diagnosis of oral
diseases and will help compensate for the lack of access to dental care for many (Martin
& Simon, 2019). It would be recommended to have medical professionals provide their
patients with a list of dental care providers to encourage the patient to seek a permanent
dental home. This would be a referral list of dental offices/practitioners who are available
at locations where the patient can have easier access and perhaps be offered a payment
plan for dental care as needed.
Studies have shown there to be an established relationship between oral health and
systemic health due to common risk factors (Hewlett et al., 2015; Andreeva et al., 2018)
promoting the interrelationship of medical and dental health care providers. The
collaborative efforts of both professions would serve to provide true comprehensive care
for their patients and achieve early detection and intervention leading to a bidirectional
referral network working to affect change not only in early detection and treatment but
also to decrease costs of care (Myers-Wright & Lamster, 2016). Previous research
investigating the link between atherosclerotic heart disease and PD has resulted in a
collaborative effort between the cardiologist and the dental team (Bale et al., 2017).
Patients awaiting cardiac surgery are required to get clearance from their dentist before
receiving any surgical interventions.
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Involving medical professionals to perform cursory dental exams would make a
difference. These cursory exams would allow the health care provider to check for signs
of bleeding gum tissue and identify teeth that are loose and extruding. Loose teeth that
are painful and sensitive to the touch do not allow the patient to eat a proper diet and
obtain nutrients that are vital to maintaining good health. Poor oral health is directly
associated with a reduced variety of diet, inadequate intake of micro and macronutrients,
and an increased risk of malnutrition (Andreeva et al. 2018). Vitamin D deficiency
affects the regulation of immune and inflammatory processes and were shown to be quite
low in patients experiencing chronic inflammatory diseases such as CKD. Vitamin D is
indicated to have an anti-inflammatory effect and will produce higher serum levels in
CKD patients who have reduced inflammation (Norris et al., 2018). The correlation
between decreased vitamin D levels and increased inflammatory states was supported by
a previous study showing vitamin D deficiency played a significant role in activating
inflammation (Mansouri et al., 2017). Oh et al., (2017) noted in their study that vitamin D
deficiency not only resulted in a decrease in the glomerular filtration rate (GFR) in the
CKD patient but also showed signs that it may affect the HRQoL for the CKD patient.
PD does result in loss of teeth and supporting tissues which are necessary for full
functioning dentition. Patients who are edentulous or have less than a full complement of
teeth are prone to poor food quality, decreased intake of fruits and vegetables, and are
more likely to have issues with obesity, diabetes, and cardiovascular diseases
(Komagamine et al., 2016).
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The medical profession has already adopted a practice of requiring patients to
have a pre-surgical dental exam and complete any necessary dental treatment prior to
having any cardiac or joint replacement surgeries. The precursory step of a dental exam
and clearance allows the dental team the opportunity to provide needed treatment and
therapy to decrease/eliminate the pathogens responsible for oral diseases, namely PD,
which have also been known to be a cause of mortality/morbidity in CVD (Bales et al.,
2017). It is necessary to increase collaborative efforts between the medical and dental
professions to foster an environment for early detection and treatment, increase positive
health outcomes, and improve the patients’ oral health status. Improved health outcomes
can lead to decreased financial burden on the patient, their family, and the managed care
programs which are funded in part by the federal health care system.
There should be continued emphasis and research exploring the relationship
between oral health and systemic disease. This study focused primarily on the impact of
PD on chronic kidney disease but there may be other implications of how much of an
effect PD may or may not have on ither systemic illnesses. As expressed earlier in this
study the WHO has noted an increase in PD worldwide as the incidence of diabetes
mellitus and oral disease has increased exponentially. This study was limited in that it
added only one other variable of mental health. There has been previous research
examining the relationship between oral health (specifically PD), and systemic diseases
and what possible impact it may have on the patient’s overall health. These studies
(Cotiĉ, 2017; Fiorillo, 2019; Johnston, Martin & Archer, 2020) have concluded that ther
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is enough evidence to assert an association does exists and further research should be
continued in that direction.
Research to explore the full impact of PD and other oral diseases on the patient’s
well-being would aid in improving the HRQoL for all patients experiencing any systemic
illness and decrease hospitalization, morbidity, and mortality rates. This decrease would
in turn affect the overall cost of care and increase positive patient outcomes. The results
of this study may also provide a basis for lobbying of inclusion of dental insurance as part
of overall health insurance eliminating a financial barrier of access to care.
Patients being seen in medical offices for monitoring of systemic illness should be
screened for oral diseases and then referred for diagnosis and treatment. Likewise,
patients being treated for dental care should have their vital signs (blood pressure, BMI
assessment, pulse, and respiratory rates) checked and monitored at each visit. Referrals to
the patient’s primary care for further assessment should be given to the patient when
these stats for the vital signs are less than optimal. The collaborative efforts of both
professions would serve to provide early detection and treatment options, avoiding
extensive and expensive care.

Implications for Social Change
This study has shown the relationship between the presence of a low grade,
chronic, inflammatory disease such as periodontal disease and its’ effect on the healthrelated outcomes for the quality of life for the chronic kidney disease patient. The study
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results show a significant relationship between PD and CKD and demonstrates the need
for continued research to examine how the low-grade, chronic inflammatory process of
PD contributes to a decreased HRQoL. Changes to how patients are diagnosed and
treated early on in their disease state can have positive social impacts including increased
self-efficacy, increased employment, better socioeconomic status, improved oral health,
and improved overall health.
Lack of access to care for many adults has created oral health
disparities/inequities to the likes of which led the former surgeon general, Dr. David
Satcher, to declare in his 2000 Oral Health in America report that oral disease is “the
silent epidemic” of disparities in oral health (Satcher & Nottingham, 2017). Poor oral
health is a significant factor in exposing social and health inequities and continues to be a
source of underemployment, low self-esteem, pain and discomfort, and low economic
capacity (Martin & Simon, 2019). Low economic capacity and self-esteem can be
directly tied to the target population of this study. Persons within the age group of 45-64
years of age have lived to more than half their life expectancy yet they are a majority in
the labor force (www.cia.gov). This large group of adults are able to be a part of the
workforce, increasing the GDP for the country, and play a vital role in the social process
of their communities. Increased health and oral literacy rates are desirable to achieve
community health and provide the necessary interventions to create and maintain healthy
communities across the country. The creation of a platform that addresses the disparities
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and health inequities many of our underserved communities experience can have a
positive impact on the suffering experienced by those with chronic diseases such as CKD.
Early diagnosis and treatment for inflammatory conditions (i.e., PD) that are risk
factors for other systemic illnesses should be addressed especially for the 45-64-year-old
persons targeted in this study. Seventeen percent of those persons within this age range
have been diagnosed with CKD and of this group 14% have been diagnosed with severe
PD. The percentages increase significantly, almost doubling for those aged 65-74 years .
(www.cdc.faststats). If PD is diagnosed early enough in the CKD population and
provided with treatment options known to be effective against the progression of the
inflammatory process, the number of CKD patients affected by PD may be dramatically
affected and reduced and in turn may reduce the progression of the kidney disease.
The results of the statistical analyses done in this study revealed the significance
of how much of an impact PD has on the HRQoL for the CKD patient. The HRQoL is a
measurable outcome that is closely monitored by healthcare administrators to aid in
determining the effectiveness of treatment modalities of chronic diseases. HRQoL is a
critical measure of the CKD patient’s total well-being and is used by the CMS to assess
the efficacy of interventions (Queeley & Campbell, 2018). These statistics present an
ever-increasing financial burden on the US government and the healthcare systems with
an annual expenditure of $30 billion to provide care for the CKD patient on dialysis
(Queeley & Campbell, 2018).
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Evidence supporting the association between oral and systemic health has been
presented earlier in this study (Araujo et al., 2015; Grubbs et al., 2016; Sharma et al.,
2017) and bears witness to the debilitating effect that non-treatment of the PD has on the
CKD patient. Myers-Wright & Lamster (2016) concluded that many oral and systemic
diseases share common risk factors accounting for two-thirds of adults are faced with
multiple chronic diseases. The revelation of PD as a focus for being a risk factor in renal
dysfunction in the CKD patient via the inflammatory process (Thompson et al., 2017)
should garner the attention of the medical community when examining methods of
controlling chronic diseases. Early diagnosis and proper treatment of PD can serve to
mitigate the causes of morbidity and mortality in CVD (Bale et al., 2017). This can occur
if both the medical and dental communities are allied in their commitment to provide
comprehensive care to their patients, recognizing the need to do their due diligence to
inform, educate, and treat their patients with the attitude of treating the patient as a whole
and not just treating the acute symptoms.
Access to basic oral health care is not only limited to CKD patients but is
universally acknowledged as a problem for many communities, particularly those of color
and the underserved (Gomaa et al., 2017). Emergency room visits related to dental care
has not decreased but instead has increased since Dr. Satcher’s declaration (Potter, 2019).
Lack of access to care and treatment are reflected in the number of emergency room
visits and even cases of death due to untreated oral disease. One such case occurred in
2007 in Prince George’s County, Maryland where a 12-year-old boy died of untreated

72
tooth decay which led to brain infection and ultimately death. His life could have been
saved by having the decayed teeth extracted but because his family had no dental
coverage it was difficult to find a dentist who would provide care (Harper et al., 2019).
This was a prime example of the underserved not being served at all. The untimely death
of this 12-year-old does not represent the target population in this study but it brings
attention to the harsh reality of the morbid outcome of untreated dental diseases.
Undiagnosed oral disease and untreated decay result in pain and discomfort on a daily
basis which can often lead to opioid addiction and substance abuse. Oral health literacy
has to be improved and that can begin with a collaborative effort between the medical
and dental professions encouraging their patients to seek both medical and dental care on
a routine and regular basis. The oral cavity is considered a gateway to systemic health
and should be treated as such.
Access to oral health care should not be considered as a tertiary care item but as a
primary concern. The loss of teeth not only affects a person’s masticatory functions but
also impacts their social well-being and self-esteem (Nazir, 2020). Physical appearance
plays an important role in how one is accepted by others in social networks and in society
in general (Lee & Jung, 2018). For most adults, a healthy smile and outward appearance,
particularly for those in the workforce, can signal increased opportunities for employment
and social networking. Healthy teeth and a beautiful smile are generally accepted as
welcoming and attractive. An unattractive smile can be the difference between
employment and not being able to have a steady income. Untreated tooth decay and
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disease can lead to loss of social activity and engaging in social networks. This can result
in diminished quality of life as it applies to a person’s socioeconomic status throughout
their life (Varenne, 2015). Increased access to dental care and early diagnosis and
treatment of disease can alter the trajectory of a patient’s quality of life. Oral health is
essential to overall general health and has plays an important role in a person’s wellbeing.
Patients are encouraged to have dental exams prior to any cardiac or joint
replacement surgical interventions as a result of that research but it has not led to major
changes in accessing dental care but has continued to be overlooked in the larger picture
(Martin & Simon, 2019). Persons with painful and untreated oral conditions are less
likely to be employed, have low self-esteem, and generally do not engage in social
networking activities. The underserved are those individuals who lack the financial
resources needed to access and obtain care and are the same individuals who are also
unemployed but are able-bodied. Poor health and painful oral conditions impede and
sometimes block the pathway to gainful employment and social networking. The age
group this study focused on was 45-64 years which represents a large segment of the
adult population. According to the CDC statistics approximately 17% of US adults in this
age category have been diagnosed and are being treated for CKD (cdc.gov/faststats). This
age group also represents a large portion of adults who could have an impact on the labor
force. The CDC also reports that 17% of adults in the 45-64 yrs age group are lowincome wage earners and most often do not have health or dental insurance

74
(cdc.gov/faststats). Lack of health/dental insurance is a barrier to access of care and most
often leads to increased disease conditions and poor health outcomes. Gomaa et al(2017)
noted in their study that persons with higher incomes and education are least likely to
suffer from chronic diseases and have a higher health literacy than those persons of lowincome wage earners. This discrepancy in health literacy plays an important role in
accessing care. Early diagnosis and treatment of a disease can be the difference between
poor and good health outcomes. Often oral lesions are the first evidence of a systemic
disease (Thompson et al., 2017) and as such oral health, specifically PD, should be
screened for in every adult patient. Of the 17% a fourth of these respondents are
unemployed or have been for more than a year, adding to the numbers of unemployed
workers. An increased labor force can translate to increased GNP production which can
lead to increased socioeconomic status and improved health outcomes. Improved health
outcomes can show a decrease in hospitalization and mortality/morbidity rates.
Reduction in systemic illness can have a significant financial impact by cutting
the expenditures for health care costs. Many individuals with CKD also experience at
least one other comorbid condition with diabetes, CVD, and hypertension being the most
common that serves to increase their inflammatory status. PD has been identified as a
low-grade chronic inflammatory process which also contributes to this condition and the
findings of this study support the evidence of a correlation between the presence of PD
and a decrease in the HRQoL for the CKD patient. Reduction in the HRQoL measures
does affect the cost of care. Consider that less than 1% of the population diagnosed with
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CKD and ESRD are covered under Medicare but their cost of care accounts for more than
7% of the total Medicare expenditures (Linn & O’Neal, 2018). The findings of the
correlational analysis and ANOVA tests show that for every 6.8% change in the HRQoL
of the CKD can be attributed to the presence of PD should warrant more attention to
early diagnosis and treatment of oral disease, specifically PD.
The intersection of oral health and general health are heavily impacted by policies
and legislation that do not consider oral health as an important component of general
health (Varenne, 2015). The integration of these two health components should be based
on common risk factors. When discussing periodontal disease tooth loss and dental decay
combined with chronic inflammation negatively impact the HRQoL of any patient (Haag
et al., 2017). The data provided by researchers (Martin et al., 2020; Fiorillo, 2019)
examining the implications of oral diseases on systemic conditions and overall health
should furnish the foundation of design interventions which address the lack of oral
health care among children, adults, and the medically compromised (disabled patients).
Failure to address the oral health needs of these underserved populations can lead to a
decreased labor workforce and an increase in overall health care costs. Follow through
on the recommendations made in this study could have a positive impact on how our
society functions and cares for all its’ citizens. Possible positive social impacts on our
society can be summarized in five basic areas and cn be connected to early diagnosis and
treatment at the outset resulting in:
•

decreased disease incidence
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•

increased access to care

•

improved mental health status

•

opportunity for better economic status, and

•

improved overall health

The possible positive social impact created by making a change in how our
citizens are able to navigate the health care system, receive necessary care, and be more
involved in their daily care can have lasting effects.

Conclusions
In the past several months soon after the outbreak of the current pandemic, this
country has seen the eruption of protests across the states which has been likened to the
protests during the Vietnam war era. The issues at the center of the protests were focused
on social injustice, inequities in the law enforcement and the legal system, and a lack of
equitable distribution of this country’s wealth. Social justice is inclusive of health care
(which includes oral health, mental health, and vision care), adequate and affordable
housing, access to healthy food, access to gainful employment, and the right to live a
decent life. Following through on the recommendations brought forth in this study may
not lead to the improvement of the aforementioned issues but it may result in better
optimization of the health care system.
Addressing the lack of oral health care for the CKD patient would have similar
implications in social change and health outcomes as it would for all patients. Improved
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oral health increases health literacy by educating the patient about the relationship
between oral and general health. Improved health outcomes and overall general health
can result in increased self-efficacy which can provide an opportunity for a change in
behavior leading to better self-management of diseases (Havas, Douglas & Bonner,
2018). Better self-management leads to more positive health outcomes, decreased
hospital visits, and increased production in the workforce which in turn affects the
economy. Decreased unemployment will in turn help boost a sagging economy and
provide better living for those at the bottom of the socioeconomic chain. Reductions in
food insecurity, homelessness, and incidents of domestic violence may lead to a reduction
of stress and anxiety and better mental health. The current pandemic that we find
ourselves in has exposed and brought to the surface society’s shortcomings and ills which
some people would rather ignore while begging for a return to the ‘old days when things
were great’. But great according to whom?
The question of whether health care is a right or a privilege can be debated over
and over but it does not address the issue of access to care which affects early diagnosis
and meaningful treatment interventions. Oral health is a primary component of general
health and should be a central part of any health care initiative. Oral diseases are among
the most common of non-communicable diseases and are preventable. Lack of treatment
can and will affect a person throughout their lifetime because of the pain and dysfunction
caused by the disease process (Varenne, 2015). To ignore oral health is to set aside a
significant part of a person’s well-being and self-esteem. To ignore oral health is to
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ignore a person’s presence and their social capital. Legislators and policymakers who
decide what is funded would not hesitate to have their oral health needs attended to
because they have the means to do so. Oral pain and discomfort simply would not be
tolerated. For those individuals who have the financial means and the access to care may
have some difficulty understanding why others are lacking what they see as routine and
affordable. But yet, have done extraordinarily little to affect change in the social ills of
the day as evidenced by continued protests and disagreements over policy and procedure.
PD affects nearly 50% of the global population and the incidence of this disease
continues to rise. Nazir (2017) concluded that nearly 30-60% of CKD patients were more
likely to develop some form of PD and those patients had a 35% increased risk of
mortality when compared to CKD patients without any form of PD. In a study by MyersWright & Lamster (2016) the authors concluded that there was strong supporting
evidence of relationship between oral health and systemic health that also share common
risk factors. The same study observed and determined that a savings of $42.4 million
could be achieved by early diagnosis and treatment of chronic illnesses of which PD is a
known risk factor and shares the same inflammatory mediators that have been identified
in other systemic chronic diseases. These conclusions in the aforementioned research
does offer a compelling reason to recognize and establish that there is a bidirectional
relationship between PD and chronic inflammatory diseases such as CKD.
It would be prudent to provide comprehensive care for those individuals who are
the underserved, the underemployed, and the disenfranchised to effectively combat
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chronic illness and prevent the rise in incidence of inflammatory diseases. Attention to
early diagnosis and treatment for oral diseases should be a primary concern for improving
overall health and reducing illness and disease. Health starts from the oral cavity
(Fiorillo, 2019). Reduction in systemic chronic diseases would lead to a reduction in the
financial burden on the healthcare system and the cost of care. It would also contribute
greatly to improved health outcomes, increased patient compliance, and better patient
self-management of chronic conditions such as CKD.
Statistics reported by the CDC show that 6 in 10 adults in the US have a chronic
disease and 4 in 10 adults have been diagnosed with 2 or more chronic diseases
(www.cdc.gov). These statistics show that over half of the US adult population have
some form of chronic illness. Health care should be a basic human right and not a
commodity that is only accessible to those who have the financial means to receive it. If
we are truly willing to protest and fight for equality among every person in this country
then we should be prepared to do what is necessary to move forward with actions that
will bring about change. We must ask ourselves, ‘what am I willing to do to change the
landscape’?
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